WO2014045323A1 - Medical pump - Google Patents

Medical pump Download PDF

Info

Publication number
WO2014045323A1
WO2014045323A1 PCT/JP2012/006036 JP2012006036W WO2014045323A1 WO 2014045323 A1 WO2014045323 A1 WO 2014045323A1 JP 2012006036 W JP2012006036 W JP 2012006036W WO 2014045323 A1 WO2014045323 A1 WO 2014045323A1
Authority
WO
WIPO (PCT)
Prior art keywords
control unit
main control
sub
unit
display
Prior art date
Application number
PCT/JP2012/006036
Other languages
French (fr)
Japanese (ja)
Inventor
朋子 上村
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Priority to PCT/JP2012/006036 priority Critical patent/WO2014045323A1/en
Publication of WO2014045323A1 publication Critical patent/WO2014045323A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14212Pumping with an aspiration and an expulsion action
    • A61M5/14228Pumping with an aspiration and an expulsion action with linear peristaltic action, i.e. comprising at least three pressurising members or a helical member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16831Monitoring, detecting, signalling or eliminating infusion flow anomalies
    • A61M2005/16863Occlusion detection
    • A61M2005/16868Downstream occlusion sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16831Monitoring, detecting, signalling or eliminating infusion flow anomalies
    • A61M2005/16863Occlusion detection
    • A61M2005/16872Upstream occlusion sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/18General characteristics of the apparatus with alarm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3368Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502User interfaces, e.g. screens or keyboards
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8206Internal energy supply devices battery-operated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/36Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests with means for eliminating or preventing injection or infusion of air into body
    • A61M5/365Air detectors

Definitions

  • the present invention relates to a medical pump for delivering a medicine to a patient.
  • an infusion pump is used, for example, in an intensive care unit (ICU) or the like, and is used to perform a liquid feeding treatment for a patient for a long time with high accuracy.
  • a predetermined drug bag (infusion bag) is arranged on the infusion pump, and an infusion tube lowered from the drug bag is sandwiched between the main body and the door, and the infusion tube is accommodated in the main body.
  • the door is held by closing the door.
  • the outer peripheral surface of the infusion tube set at a fixed position is sandwiched between a plurality of fingers in the main body and the inner surface of the door.
  • This infusion pump is a peristaltic infusion pump that feeds a drug by sequentially pressing a plurality of fingers along the length of the outer peripheral surface of the infusion tube (see Patent Document 1).
  • the infusion tube is held vertically through the infusion pump main body from top to bottom.
  • an infusion pump that holds an infusion tube in a horizontal direction in the body of the infusion pump has been proposed.
  • the infusion pump has a structure in which the infusion tube is held in the horizontal direction in the main body of the infusion pump so that the infusion tube passes vertically through the main body of the infusion pump from top to bottom. This is because the infusion tube does not get in the way even if a plurality of infusion pumps are stacked and held in a stacked state in the vertical position.
  • the upstream side of the infusion tube is disposed on the right side of the infusion pump main body, and the downstream side of the infusion tube is disposed on the left side of the infusion pump main body.
  • the drug is directed from the upstream side to the downstream side.
  • Liquid can be fed along a predetermined liquid feeding direction, and liquid can be fed correctly to the patient.
  • the medical pump of the present invention is a medical pump for delivering a medicine to a patient by pressing an infusion tube with a plurality of fingers, and is formed by a main control unit and circuit elements different from the main control unit. And a sub-control unit for controlling a controlled unit that is electrically connected to a motor for feeding the medicine and a display unit for displaying various types of information and is not directly controlled by the main control unit
  • the main control unit and the sub-control unit are medical pumps configured to monitor each other for abnormal operation. According to the said structure, each role of a main control part and a sub-control part can be divided
  • the sub control unit when the sub control unit detects an operation abnormality of the main control unit, the sub control unit controls and stops the operation of the motor so that the finger is in a predetermined position, and the main control unit When detecting an abnormal operation of the sub-control unit, the main control unit controls and stops the operation of the motor so that the finger is in a predetermined position.
  • the main control unit controls and stops the operation of the motor so that the finger is in a predetermined position.
  • a white screen is displayed on the display unit to display the operation abnormality of the main control unit, and the main control unit displays the sub control.
  • a white screen is displayed on the display unit to display the operation abnormality of the sub-control unit.
  • a buzzer for notifying the alarm is provided, and the buzzer notifies the alarm when the sub control unit detects an operation abnormality of the main control unit, and the main control unit operates the sub control unit.
  • the alarm is notified.
  • a battery monitoring unit that monitors a charging voltage abnormality of the battery is provided, and the temperature sensor is arranged in the battery monitoring unit.
  • the temperature sensor used in the said battery monitoring part is used, since it is not necessary to mount a temperature sensor as another component, reduction of a number of parts can be aimed at.
  • the display unit and an operation panel unit having operation buttons are arranged on an upper part of the main body of the medical pump, and a lower part of the main body of the medical pump is used for feeding the medicine. It is a region where a liquid feeding member is arranged.
  • the medical worker can perform the liquid feeding operation
  • the present invention can provide a medical pump that can ensure safety when a medical pump such as an infusion pump delivers a drug to a patient and can reduce costs.
  • FIG. 1 is a perspective view showing an infusion pump which is a preferred embodiment of the medical pump of the present invention.
  • FIG. 2 is a view of the infusion pump shown in FIG. 1 as viewed from the W direction.
  • the infusion pump 1 shown in FIGS. 1 and 2 is an example of a medical pump.
  • the infusion pump 1 is used, for example, in an intensive care unit (ICU, CCU, NICU) or the like, and for a patient, for example, an anticancer agent, an anesthetic agent, a chemotherapeutic agent, a blood transfusion, etc.
  • This is a micro continuous infusion pump used for performing microinjection treatment (also referred to as)) for a relatively long time with high accuracy.
  • This infusion pump 1 is used, for example, for selecting a drug to be used from a drug library and feeding the selected drug.
  • This drug library is drug information which is a drug administration setting group including drug names registered in advance in the drug library database (DB). By using this drug library, a medical worker does not have to perform complicated administration settings each time, and can select a drug and set a drug.
  • DB drug library database
  • the infusion pump 1 can accurately deliver liquid to the patient P from the medicine bag 170 filled with the medicine 171 via the clamp 179, the infusion tube 200, and the indwelling needle 172.
  • the drug is also called an infusion.
  • An infusion tube is also called an infusion line.
  • the infusion pump 1 has a main body cover 2 and a handle 2T, and the handle 2T can be extended in the N direction or stored in the T direction.
  • the main body cover 2 is also called a main body, and is integrally formed of a molded resin material having chemical resistance, and can be prevented from entering the infusion pump 1 even if a drug or the like is applied. have.
  • the main body cover 2 has the drip-proof treatment structure because the medicine 171 in the medicine bag 170 disposed above spills out or disinfects the disinfecting liquid used in the vicinity. Because there is.
  • a display unit 3 and an operation panel unit 4 are arranged on the upper portion 2 ⁇ / b> A of the main body cover 2.
  • the display unit 3 is an image display device, and uses, for example, a color liquid crystal display device. This display unit 3 can display not only information notation in Japanese but also information in a plurality of foreign languages as required.
  • the display unit 3 is disposed on the upper left side of the upper portion 2 ⁇ / b> A of the main body cover 2 and above the opening / closing cover 5.
  • the upper portion 2 ⁇ / b> A of the main body cover 2 is an upper half portion of the main body cover 2.
  • the lower part 2 ⁇ / b> B of the main body cover 2 is a lower half part of the main body cover 2.
  • a display portion 3 for displaying information and an operation panel portion 4 having a plurality of operation buttons are arranged on the upper portion 2A of the body cover 2 of the infusion pump 1, and a lower portion 2B of the body cover 2 of the infusion pump 1 is This is a region where an infusion tube 200 which is a liquid feeding member for feeding a medicine is arranged.
  • the medical worker can perform the liquid feeding operation of the medicine by the infusion pump 1 while confirming the information on the display unit 3 of the upper portion 2A of the main body cover 2.
  • the medical staff can operate the operation buttons on the operation panel unit 4 while checking the information on the display unit 3 of the upper portion 2A of the main body cover 2. For this reason, the operability of the infusion pump 1 is good.
  • the display unit 3 includes a display column 3B for a scheduled dose (mL) of drug administration, a display column 3C for an accumulated dose (mL) of drug administration, a display column 3D for a charge history, and a flow rate (mL / h).
  • a display column 3B for a scheduled dose (mL) of drug administration
  • a display column 3C for an accumulated dose (mL) of drug administration
  • a display column 3D for a charge history
  • a flow rate mL / h
  • the display unit 3 can also display a warning message.
  • the display unit 3 can change the display from, for example, a yellow display screen to a white display screen by turning on a backlight of an LED (light emitting diode).
  • the operation panel unit 4 is disposed on the right side of the display unit 3 in the upper part 2A of the main body cover 2, and the operation panel unit 4 includes, for example, a pilot lamp 4A, a fast-forward switch button 4B, and a start button as illustrated in FIG.
  • a switch button 4C, a stop switch button 4D, a menu selection button 4E, a power switch 4F, and the like are arranged.
  • an opening / closing cover 5 as a lid member is provided on the lower portion 2B of the main body cover 2 so as to be openable and closable in the R direction around the rotation shaft 5A.
  • the open / close cover 5 is a plate-like lid member that is formed long along the X direction.
  • the tube mounting part 50 and the liquid feeding drive part 60 are disposed inside the opening / closing cover 5.
  • An infusion tube 200 made of a flexible thermoplastic resin such as soft vinyl chloride is set in the tube mounting portion 50, and the infusion tube 200 is connected to the tube mounting portion 50 by closing the open / close cover 5. , And can be mounted horizontally along the X direction (T direction). Note that the X direction, the Y direction, and the Z direction in FIGS.
  • the X direction is parallel to the T direction, which is the liquid feeding direction, and is the left-right direction of the infusion pump 1.
  • the Y direction is the front-rear direction of the infusion pump 1.
  • FIG. 3 is a perspective view showing a tube mounting portion 50 for opening the opening / closing cover 5 of the infusion pump 1 shown in FIGS. 1 and 2 and mounting the infusion tube 200.
  • the tube mounting part 50 and the liquid feeding drive part 60 are provided on the main body lower part 1B side of the infusion pump 1, and the tube mounting part 50 and the liquid feeding drive part 60 are operated with the display part 3.
  • a lower portion of the panel portion 4 is provided along the X direction.
  • the tube mounting portion 50 can cover the open / close cover 5 with the open / close cover 5 when the open / close cover 5 is closed in the CR direction around the rotation shaft 5A.
  • the tube mounting portion 50 includes a bubble sensor 51, an upstream blockage sensor 52, a downstream blockage sensor 53, a tube clamp portion 270, a first infusion tube guide portion 54 at the right side position, and a left side position.
  • a second infusion tube guide portion 55 is provided.
  • an infusion tube setting direction display unit 150 for clearly displaying the T direction that is the correct liquid feeding direction when the infusion tube 200 is set is provided in the vicinity of the tube mounting unit 50. ing.
  • the infusion tube setting direction display unit 150 includes, for example, a plurality of arrows 151.
  • the infusion tube setting direction display unit 150 may be printed directly on the lower part of the tube mounting part 50, for example, or may be printed on a seal-like member and attached to the lower part of the tube mounting part 50.
  • the infusion tube setting direction display unit 150 is arranged to clearly indicate the liquid feeding direction (T direction) in the correct direction of the medicine 171 by the infusion tube 200 set inside the opening / closing cover 5.
  • the infusion tube 200 it is possible to clearly indicate the T direction, which is the direction of drug delivery. For this reason, it can prevent reliably that a medical worker will attach the infusion tube 200 by the reverse direction accidentally.
  • the open / close cover 5 is a plate-like member made of a thin molded resin member in order to reduce the weight of the infusion pump 1. Thereby, the weight of the opening / closing cover 5 can be reduced, and the structure can be simplified.
  • the opening / closing cover 5 has two hinge portions 2H and 2H that allow the tube mounting portion 50 to be covered so as to be openable and closable along the CS direction and the CR direction about the rotation shaft 5A. It is supported with respect to the main body lower part 2B.
  • the two hinge portions 2H and 2H are arranged corresponding to the first hook member 5D and the second hook member 5E, respectively.
  • an opening / closing operation lever 260 is provided at the upper right portion on the surface side of the opening / closing cover 5.
  • an infusion tube pressing member 500 On the inner surface side of the opening / closing cover 5, an infusion tube pressing member 500, a first hook member 5D, and a second hook member 5E are provided.
  • the infusion tube pressing member 500 is disposed as a long rectangular and planar protrusion along the X direction, and the infusion tube pressing member 500 is in a position facing the liquid feeding drive unit 60.
  • the infusion tube pressing member 500 has a flat surface in the X direction along the liquid feeding drive unit 60, and the infusion tube pressing member 500 closes the opening / closing cover 5 in the CR direction, A part of the infusion tube 200 is pressed between them.
  • the medical worker can set the infusion tube 200 on the lower half of the body of the infusion pump 1 along the horizontal direction while confirming the display content displayed on the display unit 3, and the infusion tube 200 is connected to the tube mounting portion. After being set to 50, the opening / closing cover 5 can cover the infusion tube 200.
  • the first hook member 5D and the second hook member 5E are mechanically simultaneously engaged with the fixing portions 1D and 1E on the lower body 1B side, so that the open / close cover 5 is As shown, the tube mounting part 50 of the main body lower part 1B is held in a closed state.
  • the first hook member 5D, the second hook member 5E, and the fixing portions 1D, 1E on the main body lower part 1B side constitute a double hook structure portion 300 of the opening / closing cover 5.
  • the tube clamp part 270 shown in FIG. 3 clamps and closes the middle part of the infusion tube 200 by closing the open / close cover 5.
  • the tube clamp portion 270 is disposed in the vicinity of the left fixed portion 1E and at a position corresponding to the left second hook member 5E.
  • the tube clamp portion 270 can block a part of the infusion tube 200 in the middle.
  • the first infusion tube guide portion 54 is provided on the right side of the main body lower portion 1B, and the second infusion tube guide portion 55 is provided on the left side of the main body lower portion 1B.
  • the first infusion tube guide portion 54 can be held by fitting the upstream side 200A of the infusion tube 200
  • the second infusion tube guide portion 55 can be held by fitting the downstream side 200B of the infusion tube 200
  • the infusion tube 200 can be held. It is held in the horizontal direction along the X direction.
  • the infusion tube 200 held in the horizontal direction is in the T direction along the bubble sensor 51, the upstream block sensor 52, the liquid feed drive unit 60, the downstream block sensor 53, and the tube clamp unit 270. It is fixed by fitting along.
  • the second infusion tube guide portion 55 is a groove portion formed in the side surface portion 1 ⁇ / b> S of the main body lower portion 1 ⁇ / b> B in order to detachably hold a part of the downstream side 200 ⁇ / b> B of the infusion tube 200. is there.
  • the first infusion tube guide portion 54 and the second infusion tube guide portion 55 are provided in the tube attachment portion 50 so that the infusion tube 200 is not sandwiched between the opening / closing cover 5 and the tube attachment portion 50 and crushed. Can be installed securely.
  • the bubble sensor 51 shown in FIG. 3 is a sensor that detects bubbles (air) generated in the infusion tube 200.
  • the bubble sensor 51 flows into the infusion tube 200 from the outside of the infusion tube 200 such as soft vinyl chloride.
  • It is an ultrasonic sensor that monitors bubbles contained in a medicine.
  • the receiving unit monitors the presence or absence of bubbles by detecting the difference in transmittance.
  • the bubble sensor 51 has a pressing member 320 and a receiving member 330.
  • the ultrasonic oscillator is disposed on the pressing member 320.
  • the ultrasonic wave receiver is disposed on the receiving member 330.
  • the upstream blockage sensor 52 shown in FIG. 3 is a sensor that detects whether or not the inside of the infusion tube 200 is blocked on the upstream side 200A of the infusion tube 200, and the downstream blockage sensor 53 is an infusion solution on the downstream side 200B of the infusion tube 200. It is a sensor that detects whether or not the inside of the tube 200 is closed.
  • the upstream blockage sensor 52 and the downstream blockage sensor 53 have the same configuration.
  • the case where the infusion tube 200 is blocked is, for example, a case where the viscosity of the medicine to be delivered is high or the concentration of the medicine is high. As shown in FIG.
  • pressing members 452 and 453 are provided on the inner surface side of the opening / closing cover 5 at positions corresponding to the upstream closing sensor 52 and the downstream closing sensor 53, respectively.
  • the infusion tube 200 of any size among the plural types of infusion tubes 200 having different diameters is attached to the infusion pump 1, when the open / close cover 5 is closed, the upstream side occlusion sensor 52 and the downstream side occlusion sensor 53 are The occlusion state of the infusion tube 200 can be detected.
  • FIG. 4 shows an electrical configuration example of the infusion pump 1.
  • the infusion pump 1 has a main control unit 100 and a sub control unit 400.
  • the liquid feeding drive unit 60 includes a drive motor 61, a cam structure 62 having a plurality of eccentric cams that are rotationally driven by the drive motor 61, and cams (eccentric cams 62A to 62F) of the cam structure 62.
  • a finger 63 having a plurality of fingers to be moved is provided.
  • the cam structure 62 has a plurality of eccentric cams, for example, a plurality of eccentric cams 62A to 62F, and the finger structure 63 has a plurality of fingers 63A to 63F corresponding to the plurality of eccentric cams 62A to 62F. is doing.
  • the plurality of eccentric cams 62A to 62F are arranged with a phase difference from each other, and the cam structure 62 is connected to the output shaft 61A of the drive motor 61.
  • the cam structure 62 supported by the output shaft 61A rotates, and the plurality of fingers 63A to 63F are sequentially moved in the Y direction by a predetermined stroke (top dead center and bottom dead center).
  • the infusion tube 200 is pressed against the infusion tube holding member 500 of the opening / closing cover 5 along the T direction. For this reason, the medicine in infusion tube 200 can be sent in the T direction.
  • the plurality of fingers 63A to 63F sequentially advance and retract by a predetermined stroke in the Y direction, so that the infusion tube 200 moves in the T direction.
  • the medicine in infusion tube 200 can be sent in the T direction. That is, when the plurality of fingers 63A to 63F are individually driven, the plurality of fingers 63A to 63F sequentially press the outer peripheral surface of the infusion tube 200 along the T direction to feed the medicine in the infusion tube 200. .
  • the sub-control unit 400 controls the peristaltic motion of the plurality of fingers 63A to 63F, thereby causing the fingers 63A to 63F to move forward and backward in sequence, so that the wave travels, so that the blocking point of the infusion tube 200 is increased. Is moved in the T direction to squeeze the infusion tube 200 and transfer the medicine.
  • the infusion pump 1 has the main control unit 100 and the sub control unit 400.
  • the main control unit 100 is a first control unit
  • the sub control unit 400 is a second control unit.
  • the main control unit 100 employs a CPU (central control unit) chip
  • the sub-control unit 400 preferably employs an FPGA (Field-Programmable Gate Array).
  • the FPGA is a device that can realize a logic function desired by the user in a short period of time using the user's own computer, and is less expensive than a CPU.
  • the main control unit 100 uses, for example, a one-chip microcomputer to control the overall operation, and includes a ROM (Read Only Memory) 101, a RAM (Random Access Memory) 102, a non-volatile memory 103, and A clock 104 is included.
  • the clock 104 can correct the current time by a predetermined operation, and can acquire the current time, measure the elapsed time of a predetermined liquid feeding operation, measure the reference time of liquid feeding speed control, and the like.
  • the main control unit 100 and the sub control unit 400 shown in FIG. 4 are electrically connected, and perform mutual monitoring and monitoring of peripheral elements. That is, the main control unit 100 monitors abnormal operations (for example, runaway operation) of the sub-control unit 400 and monitors peripheral elements directly connected to the main control unit 100. On the other hand, the sub control unit 400 monitors abnormal operations (for example, runaway operation) of the main control unit 100 and controls and monitors peripheral elements connected to the sub control unit 400.
  • the main control unit 100 illustrated in FIG. 4 is directly connected to the following peripheral elements. Directly connected to the main control unit 100 are a battery monitoring unit 181, a power converter unit 112, and a battery 113.
  • the main control unit 100 is connected to a power switch button 4F, a power switch 111, a display driver 130, a drive motor 61, a speaker 131, a buzzer 132, and an information terminal 600 on the nurse center side.
  • This switch 111 supplies power to the main control unit 100 from one of the power converter unit 112 and the battery 113 by switching between the power converter unit 112 and the battery 113.
  • the power converter unit 112 is connected to a commercial AC power source 115 via an outlet 114.
  • the battery 113 is a rechargeable secondary battery such as a lithium ion battery.
  • the main control unit 100 can charge the battery 113 from the power converter unit 112 by issuing a charge command signal CZ and turning on the charging switch 199.
  • the main control unit 100 cancels the charging command signal CZ, charging of the battery 113 can be stopped.
  • the main control unit 100 is also connected to an upstream blockage sensor 52 and a downstream blockage sensor 53 as necessary. Thereby, the main control unit 100 can also monitor the closed state in the infusion tube 200.
  • the temperature sensor 180 measures the temperature when the battery 113 of the infusion pump 1 is operating, and notifies the main controller 100 of the temperature measurement result as a temperature sensor value (A / D value) TS. Thereby, main controller 100 can detect the abnormal state of battery 113 from the temperature during operation of battery 113.
  • the battery monitoring unit 181 is an integrated circuit for battery monitoring, monitors whether the voltage values obtained from the power converter unit 112 and the battery 113 are within a predetermined value range, and monitors the main control unit 100. A signal QS is supplied. As a result, the main control unit 100 can monitor the charging voltage abnormality of the battery 113.
  • a ROM 185 is connected between the main control unit 100 and the sub control unit 400 shown in FIG. Further, another ROM 190 is connected to the sub-control unit 400.
  • These ROMs 185 and 190 use a kind of semiconductor memory, for example, a flash ROM (Flash ROM). Data can be freely erased and written, and the data contents are not lost even when the power is turned off. .
  • the ROM 185 stores arbitrary data for the main control unit 100 to write from the main control unit 100 to the sub control unit 400 in order to detect an abnormal operation of the sub control unit 400, for example.
  • the ROM 190 stores a program for operating the sub control unit 400.
  • the sub-control unit 400 includes a display unit driver 130, an error display lamp 3W, a speaker 131, a buzzer 132, a bubble sensor 51, an upstream block sensor 52, a downstream block sensor 53, a communication port 140, an operation panel (
  • the operation button 4 is electrically connected to the information terminal 600 on the nurse center side, and these peripheral elements are managed and controlled.
  • An information terminal 600 on the nurse center side is placed in the nurse center 650, and the display unit 3T, error display lamp 3WT, speaker 131T, buzzer similar to the display unit 3, error display lamp 3W, speaker 131, and buzzer 132 described above. 132T.
  • the display unit driver 130 in FIG. 4 drives the display unit 3 according to a command from the main control unit 100 or a command from the sub control unit 400, displays information contents and warning messages illustrated in FIG. 2, and LED (light emitting diode). Turn on the backlight.
  • the error display lamp 3W is turned on when either the main control unit 100 or the sub control unit 400 fails.
  • the speaker 131 can notify various alarm contents by voice according to a command from the main control unit 100 or a command from the sub-control unit 400.
  • the buzzer 132 can notify various alarms by sound according to a command from the main control unit 100 or a command from the sub-control unit 400.
  • a downstream blocking signal S3 indicating that the side is blocked is supplied to the sub-control unit 400.
  • the upstream blockage sensor 52 and the downstream blockage sensor 53 can detect a state in which the internal pressure of the infusion circuit exceeds the set pressure in the infusion pump 1 and the medicine cannot be delivered.
  • the reason why the internal pressure of the infusion circuit exceeds the set pressure in the infusion pump 1 is that when the infusion needle for infusion or the infusion tube 200 is clogged, the infusion tube 200 is crushed or broken, a highly viscous drug This is the case when using.
  • the sub-control unit 400 can communicate bidirectionally with a computer 141 such as a desktop computer through the communication port 140.
  • the computer 141 is connected to a drug database (DB) 160, and drug information MF stored in the drug database 160 is acquired by the sub-control unit 400 via the computer 141, and the sub-control unit 400 It can be stored in the ROM 101.
  • the sub-control unit 400 can display the drug information MF and the like on the display unit 3 shown in FIG. 2, for example, based on the stored drug information MF.
  • FIG. 5 is a flowchart showing an operation example of the infusion pump 1.
  • the main control unit 100 and the sub control unit 400 are activated to perform mutual monitoring and monitoring of peripheral elements. . That is, the main control unit 100 monitors abnormal operations (for example, runaway operation) of the sub-control unit 400 and monitors peripheral elements directly connected to the main control unit 100.
  • the sub-control unit 400 monitors the abnormal operation (for example, runaway operation) of the main control unit 100 and controls and monitors the peripheral elements connected to the sub-control unit 400.
  • the sub-control unit 400 shown in FIG. 4 operates the drive motor 61 of the liquid feeding drive unit 60, the cam structure 62 presses the infusion tube 200, thereby feeding the drug along the liquid feeding direction T. Do.
  • step ST2 the sub-control unit 400 monitors an abnormal operation of the main control unit 100 by a watch dog timer (WDT).
  • WDT watch dog timer
  • the abnormal operation of the main control unit 100 is an abnormality that occurs when the microcomputer used in the main control unit 100 is not operating normally. Therefore, the sub-control unit 400 checks whether the main control unit 100 is operating normally or abnormally using a timer called a watchdog timer.
  • This watchdog timer is one of the methods for checking whether the main control unit 100 is operating normally.
  • a normal processing routine called watchdog timer
  • the watchdog timer starts a timer that is reset by an instruction within a certain period of time, and if the timer has not been reset even after this certain period of time has elapsed. Then, it is determined that the program has entered an abnormal processing routine, and an interruption is generated to detect an abnormal operation of the main control unit 100.
  • the sub-control unit 400 is programmed to execute, for example, a certain command to the main control unit 100 so that the same command is executed again even after a predetermined time elapses.
  • the sub-control unit 400 determines that an abnormality has occurred in the hardware of the main control unit 100. However, the sub control unit 400 does not forcibly reset the operation of the main control unit 100. For this reason, the main control unit 100 plays a higher role with respect to the sub control unit 400, but even if the sub control unit 400 determines that an abnormality has occurred in the hardware of the main control unit 100, Since the main control unit 100 is not necessarily in an abnormal state, the main control unit 100 does not enter the reset state, but executes various countermeasures as shown in step ST3.
  • step ST2 of FIG. 5 when the sub control unit 400 shown in FIG. 4 determines that an abnormality has occurred in the hardware of the main control unit 100, in step ST3, the sub control unit 400 displays the display unit driver 130 of FIG.
  • the display unit driver 130 causes the display unit 3 to display “main control unit 100 (CPU) error”.
  • the display color of the liquid crystal display device of the display unit 3 is changed from, for example, a yellow screen to a “white screen” in order to increase the visibility for the medical staff. “Error” is displayed.
  • the medical staff sees the error display on a “white screen” different from the display color of the normal display unit 3, so that the error of the main control unit 100 can be easily and reliably visually recognized. .
  • step ST3 the sub-control unit 400 turns on the red LED of the error display lamp 3W, turns on the buzzer 132, stops the operation of the drive motor 61, and stops the medicine feeding operation. To do. Further, if necessary, the sub-control unit 400 issues a nurse call signal by issuing a “main control unit 100 (CPU) error” to the medical staff through the speaker 131 by voice. In this step ST3, preferably, the sub-control unit 400 notifies the medical staff of “main control unit 100 (CPU) error” also to the information terminal 600 on the nurse center side.
  • the display color of the liquid crystal display device of the display unit 3 is changed from, for example, a yellow screen to a “white screen” by turning on the backlight, and “CPU Error” is displayed on the “white screen”.
  • the sub-control unit 400 “red-lights” the red LED of the error display lamp 3WT, rings the buzzer 132T, and medically reports “main control unit 100 (CPU) error” by voice through the speaker 131T.
  • a nurse call signal is issued by issuing to a worker.
  • step ST4 the main control unit 100 now monitors the operation abnormality of the sub control unit 400.
  • the main control unit 100 writes arbitrary different data in the register of the sub-control unit 400 to the error check register (WRITE).
  • the main control unit 100 reads the data written in the error check register in the sub control unit 400 (READ).
  • the main control unit 100 verifies (inspects) the data by comparing the written data with the read data.
  • This arbitrary data is stored, for example, in the ROM 185 shown in FIG.
  • the main control unit 100 compares the written data with the read data, and if the written data and the read data are different, the main control unit 100 indicates that the sub-control unit 400 has malfunctioned. Judge that.
  • step ST4 when the main control unit 100 determines that the sub control unit 400 is operating abnormally, the main control unit 100 moves to step ST5 and performs the next operation.
  • step ST5 the main control unit 100 forces the sub control unit 400 to be in a reset state.
  • the main control unit 100 forcibly stops the command operation of the sub control unit 400 by forcing the sub control unit 400 into the reset state.
  • priority is given to safety.
  • the main control unit 100 issues a command to the display unit driver 130 of FIG. 4, and the display unit driver 130 causes the display unit 3 to display “sub control unit 400 (FPGA) error”.
  • FPGA sub control unit 400
  • the display color of the liquid crystal display device of the display unit 3 is changed from a yellow screen to a “white screen”, for example, by turning on the backlight in order to increase the visibility for the medical staff.
  • “FPGA Error” is displayed.
  • step ST5 the main control unit 100 turns on the red LED of the error display lamp 3W to “red light”, sounds the buzzer 132, and stops the operation of the drive motor 61. Further, as necessary, the sub-control unit 400 issues a nurse call signal by issuing a “sub-control unit 400 (FPGA) error” to the medical staff through the speaker 131 by voice. In this step ST5, preferably, the main control unit 100 notifies the medical staff of the “sub control unit 400 (FPGA) error” also to the information terminal 600 on the nurse center side. As a result, the display color of the liquid crystal display device of the display unit 3 is changed from, for example, a yellow screen to a “white screen” by turning on the backlight to display “FPGA Error”.
  • step ST3 the main control unit 100 “red-lights” the red LED of the error display lamp 3WT, sounds the buzzer 132T, and performs a medical “sub-control unit 400 (FPGA) error” by voice through the speaker 131T.
  • a nurse call signal is issued by issuing to a person.
  • step ST4 when the main control unit 100 determines that the sub control unit 400 is not operating abnormally, the main control unit 100 moves to step ST6, and when the infusion pump 1 delivers a predetermined amount of drug to the patient, The normal liquid feeding operation performed so far is stopped.
  • the control for stopping the drive motor 61 of the liquid supply drive unit 60 by the main control unit 100 or the sub-control unit 400 is the same whether the normal liquid supply operation is stopped or the liquid supply operation is stopped in the event of an abnormality. .
  • the flow of feeding the medicine 171 in the infusion tube 200 by the finger structure 63 of the liquid feeding drive unit 60 pressing the infusion tube 200 will be described first.
  • FIG. 6 (A) to 6 (F) show a so-called mid-press type liquid feeding drive unit 60 that pushes the inside of the infusion tube 200 and feeds the medicine 171 by squeezing the infusion tube 200 in the T direction. Show. However, the liquid feeding drive unit 60 feeds the medicine 171 in the infusion tube 200 by pressing the infusion tube 200 without completely crushing it. Thus, in this example, the fingers 63C, 63D, and 63E do not completely crush the infusion tube 200 among the finger structures 63 of the mid-press type liquid feeding drive unit 60. The infusion tube 200 can be crushed by a certain amount within the range where there is little settling, and the required amount of the drug 171 can be accurately fed. In FIG.
  • the infusion tube 200 is completely closed by the finger 63B located at the top dead center, and the drug 171 flows in the infusion tube 200 in the T direction.
  • the inflow of the medicine 171 is stopped, and the infusion tube 200 is completely closed by the finger 63F located at the top dead center, so that a certain amount of the medicine 171 is infused.
  • the finger 63B at the bottom dead center is released from pushing the infusion tube 200, the finger 63E at the top dead center pushes the infusion tube 200, and FIG.
  • the fingers 63D and 63C at the top dead center position push the infusion tube 200 to discharge the medicine 171 in the T direction.
  • the finger 63E and the fingers 63D and 63C that are at the top dead center do not completely crush the infusion tube 200.
  • the finger 63B at the top dead center again completely closes the infusion tube 200 again, and stops the discharge of the medicine 171 in the T direction.
  • the finger 63B at the bottom dead center is released from pushing the infusion tube 200, thereby returning to the initial state of FIG. 6 (A).
  • the main control unit 100 or the sub-control unit 400 causes the finger 63B to reach the top dead center position, and the infusion tube 200 is completely removed.
  • the liquid feeding operation is stopped in a state where the pressure is closed.
  • the delivery is performed with the most downstream finger at the top dead center position (predetermined position). Stop fluid operation.
  • the method for stopping the drive motor with a syringe pump is to stop applying a pulse-shaped input current waveform for two-phase excitation for forward rotation from the motor driver of the stepping motor according to the command of the control unit, Control to stop the forward rotation of the magnet rotor of the drive motor.
  • the main control unit 100 and the sub control unit 400 can monitor each other, and the main control unit 100 can monitor abnormal operation (for example, runaway operation) of the sub control unit 400. 400 can monitor abnormal operation (for example, runaway operation) of the main control unit 100.
  • the main control unit 100 and the sub control unit 400 monitor the following peripheral elements, for example.
  • the main control unit 100 monitors the rotation detection signal of the drive motor 61 via the sub control unit 400 for the rotation abnormality of the drive motor 61 shown in FIG.
  • the main control unit 100 monitors the operating state of the battery 113 by directly monitoring the temperature sensor value (A / D value) TS of the temperature sensor 180 without passing through the sub-control unit 400, thereby causing abnormal operation. Sometimes, for example, it is displayed on the display unit 3 and an alarm is given by the buzzer 132.
  • the main control unit 100 directly obtains the monitoring signal (battery voltage detection value (A / D value)) QS without passing through the sub-control unit 400, thereby monitoring the charging voltage abnormality of the battery 113 and charging voltage abnormality. Is displayed on the display unit 3, for example, and an alarm is given by the buzzer 132.
  • the main control unit 100 monitors the presence / absence of bubbles in the infusion tube by the signal S1 of the bubble sensor 51 via the sub-control unit 400, displays the bubble on the display unit 3, and alerts the buzzer 132, for example. You can also
  • the main control unit 100 is also connected to an upstream blockage sensor 52 and a downstream blockage sensor 53 as necessary. As a result, the main control unit 100 can directly monitor the closed state in the infusion tube 200 by directly obtaining the signal S2 from the upstream blockage sensor 52 and the signal S3 from the downstream blockage sensor 53.
  • the main control unit 100 can also monitor the key input signal when the button (key) of the operation panel 4 is continuously turned on via the sub control unit 400.
  • the infusion pump 1 includes a main control unit 100 and a sub control unit 400 as illustrated in FIG. 4, and an FPGA is used as the sub control unit 400.
  • the battery monitoring unit 181, the power converter unit 112, and the battery 113 are directly connected to the main control unit 100 as peripheral elements, for example. As described above, the battery monitoring unit 181, the power supply converter unit 112, and the battery 113 are directly connected to the main control unit 100 without passing through the sub-control unit 400. It is most important to supply power from the converter unit 112 or the battery 113 to the main control unit 100.
  • the main control unit 100 and the sub control unit 400 perform mutual monitoring, monitor peripheral elements, and use them properly.
  • the main control unit 100 monitors, for example, a situation in which a temperature abnormality of the battery 113 or a charging voltage abnormality of the battery 113 occurs, or a situation in which power is not supplied, as the most important monitoring items regarding safety in use. Therefore, the safety of the patient who receives the liquid can be ensured.
  • the sub-control unit 400 monitors other functions. As a result, the main control unit 100 does not incorporate all the functions described above, but the main control unit 100 and the sub control unit 400 share the functions. For this reason, it is not necessary to use a high-performance and expensive CPU (central processing unit) chip as the main control unit 100, and an inexpensive CPU chip with reduced performance can be used. Even if it is used, the cost of the main control unit 100 can be reduced.
  • a medical pump is a medical pump for feeding a drug to a patient, and includes a main control unit, a main control unit, a motor for feeding the drug, and various types of information.
  • the main control unit and the sub control unit are configured to mutually monitor an abnormal operation.
  • the main control unit can separate the roles of the main control unit and the sub control unit. For this reason, it is possible to ensure the safety when the medical pump delivers the medicine to the patient, and furthermore, it is possible to use an inexpensive central processing unit with reduced performance as the main control unit, thereby reducing the cost.
  • the main control unit can directly monitor the power supply from the battery, which is the most important for the medical pump, and the temperature of the battery from the temperature sensor, so that the medical pump can ensure the safety when sending the medicine to the patient, In addition, since an inexpensive one with reduced performance can be used as the main control unit, the cost can be reduced.
  • the sub control unit When the sub control unit detects an operation abnormality of the main control unit, the sub control unit stops the operation of the motor, and when the main control unit detects an operation abnormality of the sub control unit, the main control unit stops the operation of the motor. Thereby, even if any of the main control unit and the sub-control unit operates abnormally, the operation of the motor can be stopped, so that the liquid feeding operation of the medicine can be stopped, and when the medicine is fed, the main control section Safety can be ensured regardless of whether there is a problem with either of the sub-control unit.
  • a white screen is displayed on the display unit to display an operation error of the main control unit
  • the display unit displays a white screen and displays an abnormal operation of the sub-control unit.
  • the buzzer has a buzzer for notifying the alarm, and the buzzer notifies the alarm when the sub control unit detects an operation abnormality of the main control unit, and notifies the alarm when the main control unit detects the operation abnormality of the sub control unit.
  • the buzzer can notify the alarm, so the medical staff can confirm by hearing whether the main control unit or the sub control unit operates abnormally. can do.
  • a battery monitoring unit that monitors battery charging voltage abnormality is provided, and the temperature sensor is disposed in the battery monitoring unit. Thereby, since the temperature sensor used in the battery monitoring unit is used, there is no need to mount the temperature sensor as a separate part, so the number of parts can be reduced.
  • a display unit for displaying information and an operation panel unit having operation buttons are arranged on the upper part of the main body of the medical pump, and a lower part of the main body of the medical pump is a liquid feeding member for feeding a medicine Is an area to be placed.
  • the medical worker can perform the liquid feeding operation of the medicine by the medical pump while confirming the information on the display unit on the upper part of the main body.
  • the medical worker can operate the operation buttons on the operation panel unit while confirming the information on the display unit on the upper part of the main body.
  • the present invention is not limited to the above embodiment, and various modifications can be made without departing from the scope of the claims.
  • the embodiment of the medical pump of the present invention is the infusion pump 1
  • the present invention is not limited to this, and another embodiment of the medical pump of the present invention may be a syringe pump.
  • This syringe pump is used in, for example, an intensive care unit (ICU), etc., and performs high-accuracy treatment of a liquid such as an anticancer agent, anesthetic agent, chemotherapeutic agent, blood transfusion, etc. for a patient. Used for a relatively long time.
  • the flow rate control of the drug in the syringe pump is precise and superior compared to other infusion pumps.
  • the syringe body filled with the medicine is mounted so that it does not move using the clamp against the syringe pump housing, and the syringe pump presses the syringe pusher to accurately deliver the medicine in the syringe body to the patient side. To do.
  • a plurality of types of syringes having different accommodation amounts are prepared in advance.
  • a medical worker selects a required amount of syringe from a plurality of types of syringes, and attaches the selected amount of syringe to the above-described syringe pump.
  • the outer peripheral surface of the syringe main body is brought into close contact with the inner surface of the concave portion of the syringe pump, and the main body flange can be gripped by the inset portion of the syringe pump.
  • the syringe pump motor is driven, and the pressing member of the syringe pump gradually pushes the pusher flange of the syringe pusher toward the syringe body, so that the medicine in the syringe body is sent to the patient through the tube. It comes to liquefy.
  • a display unit for displaying information and an operation panel unit having operation buttons are arranged, and the lower part of the main body of the syringe pump is a liquid feeding member for feeding a medicine. This is an area where a syringe and a tube connected to the syringe are arranged.
  • the medical worker can perform the liquid feeding operation of the medicine by the syringe pump while confirming the information on the display part of the upper part of the main body. Then, the medical worker can operate the operation buttons on the operation panel unit while confirming the information on the display unit on the upper part of the main body.
  • a part of each configuration of the above embodiment can be omitted, or can be arbitrarily combined so as to be different from the above.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

[Problem] To provide a medical pump, such as an infusion pump, that involves reduced costs and that can ensure safety when the medical pump delivers a medicine to a patient. [Solution] This infusion pump (1) serving as a medical pump comprises: a main control unit (100); an auxiliary control unit (400) that is electrically connected to the main control unit (100), a motor (61) for delivering a medicine, and a display unit (3) for displaying various types of information; a battery (113) that supplies power to the main control unit (100); and a temperature sensor (180) that detects the temperature of the battery. The battery (113) and the temperature sensor (180) are connected directly to the main control unit (100). The main control unit (100) and the auxiliary control unit (400) mutually monitor operation abnormalities.

Description

医療用ポンプMedical pump
 本発明は、薬剤を患者へ送液するための医療用ポンプに関する。 The present invention relates to a medical pump for delivering a medicine to a patient.
 医療用ポンプの一例として輸液ポンプは、例えば集中治療室(ICU)等で使用され、患者に対して薬剤の送液処置を、高い精度で比較的長時間行うことに用いられている。輸液ポンプの上には所定の薬剤バッグ(輸液バッグ)が配置され、本体と開閉扉との間には、薬剤バッグから下げた輸液チューブを挟みこんで、この輸液チューブを本体内に収容して開閉扉を閉じることで保持している。輸液ポンプの本体内では、定位置にセットされた輸液チューブの外周面が、本体内の複数のフィンガと開閉扉の内面との間に挟まれている。この輸液ポンプは、複数のフィンガを輸液チューブの外周面を長さ方向に沿って順次押圧して薬剤の送液を行う蠕動式輸液ポンプである (特許文献1を参照)。 As an example of a medical pump, an infusion pump is used, for example, in an intensive care unit (ICU) or the like, and is used to perform a liquid feeding treatment for a patient for a long time with high accuracy. A predetermined drug bag (infusion bag) is arranged on the infusion pump, and an infusion tube lowered from the drug bag is sandwiched between the main body and the door, and the infusion tube is accommodated in the main body. The door is held by closing the door. In the main body of the infusion pump, the outer peripheral surface of the infusion tube set at a fixed position is sandwiched between a plurality of fingers in the main body and the inner surface of the door. This infusion pump is a peristaltic infusion pump that feeds a drug by sequentially pressing a plurality of fingers along the length of the outer peripheral surface of the infusion tube (see Patent Document 1).
 特許文献1に記載の輸液ポンプでは、輸液チューブを輸液ポンプの本体内において上から下に向けて垂直に通して保持している。これに対して、輸液チューブを輸液ポンプの本体内において水平方向に通して保持する輸液ポンプが提案されている。このように、輸液チューブを輸液ポンプの本体において水平方向に通して保持する構造を採用しようとするのは、輸液チューブが輸液ポンプの本体内を上から下に向けて垂直に通っている輸液ポンプとは異なり、複数の輸液ポンプを上下位置にスタックした状態で重ねて保持しても輸液チューブが邪魔にならないという利点があるからである。例えば、輸液ポンプの本体に対して向かって右側部分に輸液チューブの上流側が配置され、輸液ポンプの本体に対して向かって左側部分に輸液チューブの下流側が配置されるように予め決められている。この場合には、輸液チューブの上流側を輸液ポンプの本体の右側部分に配置し、輸液チューブの下流側を輸液ポンプの本体の左側部分に配置すれば、薬剤は上流側から下流側に向かって予め定めた送液方向に沿って送液でき、患者に対して正しく送液できる。 In the infusion pump described in Patent Document 1, the infusion tube is held vertically through the infusion pump main body from top to bottom. On the other hand, an infusion pump that holds an infusion tube in a horizontal direction in the body of the infusion pump has been proposed. In this way, the infusion pump has a structure in which the infusion tube is held in the horizontal direction in the main body of the infusion pump so that the infusion tube passes vertically through the main body of the infusion pump from top to bottom. This is because the infusion tube does not get in the way even if a plurality of infusion pumps are stacked and held in a stacked state in the vertical position. For example, the upstream side of the infusion tube is disposed on the right side of the infusion pump main body, and the downstream side of the infusion tube is disposed on the left side of the infusion pump main body. In this case, if the upstream side of the infusion tube is arranged on the right side portion of the main body of the infusion pump and the downstream side of the infusion tube is arranged on the left side portion of the main body of the infusion pump, the drug is directed from the upstream side to the downstream side. Liquid can be fed along a predetermined liquid feeding direction, and liquid can be fed correctly to the patient.
特開2010-200775号公報JP 2010-200775 A
 ところで、輸液ポンプの本体内には、電源部、表示部、ブザー、そしてモータ等の電気的な構成要素が収容されている。これらの電気的な構成要素の動作の制御は、1つのCPU(中央処理部)により行われている。しかし、1つのCPUが、これらの構成要素の動作の制御を行っているので、性能の高い高価なCPUを採用する必要がある。もし、このCPUに不具合が生じても、医療従事者はそのCPUを認知することができず、輸液ポンプは正常に動作しなくなって薬剤を患者へ安全に送液できなくなるおそれがある。
 そこで、本発明は、輸液ポンプのような医療用ポンプが患者に対して薬剤を送液する際の安全性を確保することができ、コストダウンが図れる医療用ポンプを提供することを目的とする。
Incidentally, electrical components such as a power supply unit, a display unit, a buzzer, and a motor are accommodated in the main body of the infusion pump. Control of the operation of these electrical components is performed by one CPU (central processing unit). However, since one CPU controls the operation of these components, it is necessary to employ an expensive CPU with high performance. If a malfunction occurs in the CPU, the medical staff cannot recognize the CPU, and the infusion pump may not operate normally, and the medicine may not be safely delivered to the patient.
Then, this invention aims at providing the medical pump which can ensure the safety | security at the time of a medical pump like an infusion pump sending a chemical | medical agent with respect to a patient, and can aim at cost reduction. .
 本発明の医療用ポンプは、複数のフィンガにより輸液チューブを押圧することで薬剤を患者に送液するための医療用ポンプであって、主制御部と、前記主制御部と異なる回路素子により形成されており、前記薬剤を送液するためのモータと、各種の情報を表示するための表示部に電気的に接続され前記主制御部が直接制御しない被制御部を制御するための副制御部と、前記主制御部と前記副制御部は、相互に動作異常を監視する構成としたことを特徴とする医療用ポンプである。上記構成によれば、主制御部と副制御部のそれぞれの役割を分けて、異なる回路素子で形成できすることができる。このため、医療用ポンプが患者に対して薬剤を送液する際の安全性を確保でき、しかも主制御部としては性能を落とした安価な中央処理部として、副制御部と異なる回路素子を使用できるので、コストダウンが図れる。 The medical pump of the present invention is a medical pump for delivering a medicine to a patient by pressing an infusion tube with a plurality of fingers, and is formed by a main control unit and circuit elements different from the main control unit. And a sub-control unit for controlling a controlled unit that is electrically connected to a motor for feeding the medicine and a display unit for displaying various types of information and is not directly controlled by the main control unit The main control unit and the sub-control unit are medical pumps configured to monitor each other for abnormal operation. According to the said structure, each role of a main control part and a sub-control part can be divided | segmented, and it can form with a different circuit element. For this reason, it is possible to ensure the safety when the medical pump delivers the drug to the patient, and the main control unit uses a circuit element different from the sub control unit as an inexpensive central processing unit with reduced performance. You can reduce costs.
 好ましくは、前記副制御部が前記主制御部の動作異常を検出すると、前記副制御部は前記フィンガが所定位置になるように前記モータの動作を制御して停止させ、前記主制御部が前記副制御部の動作異常を検出すると、前記主制御部は前記フィンガが所定位置になるように前記モータの動作を制御して停止させることを特徴とする。
 上記構成によれば、主制御部と副制御部のいずれが異常動作しても、モータの動作を停止できるので、薬剤の送液動作を中止することができ、薬剤を送液する際に、主制御部と副制御部のいずれに不具合があっても、安全性を確保できる。
Preferably, when the sub control unit detects an operation abnormality of the main control unit, the sub control unit controls and stops the operation of the motor so that the finger is in a predetermined position, and the main control unit When detecting an abnormal operation of the sub-control unit, the main control unit controls and stops the operation of the motor so that the finger is in a predetermined position.
According to the above configuration, even if either the main control unit or the sub-control unit operates abnormally, the operation of the motor can be stopped, so that the liquid feeding operation of the medicine can be stopped, and when the medicine is fed, Safety can be ensured regardless of whether the main control unit or the sub-control unit is defective.
 好ましくは、前記副制御部が、前記主制御部の動作異常を検出すると、前記表示部では白色画面が表示されて前記主制御部の動作異常を表示し、前記主制御部が、前記副制御部の動作異常を検出すると、前記表示部では白色画面が表示されて前記副制御部の動作異常を表示することを特徴とする。
 上記構成によれば、主制御部と副制御部のいずれが異常動作しても、表示部は白色画面を表示しながら主制御部の動作異常あるいは副制御部の動作異常を表示できるので、医療従事者は主制御部と副制御部のいずれの異常動作をしても視覚で確認することができる。
Preferably, when the sub control unit detects an operation abnormality of the main control unit, a white screen is displayed on the display unit to display the operation abnormality of the main control unit, and the main control unit displays the sub control. When an operation abnormality of the unit is detected, a white screen is displayed on the display unit to display the operation abnormality of the sub-control unit.
According to the above configuration, even if either the main control unit or the sub control unit operates abnormally, the display unit can display the operation abnormality of the main control unit or the sub control unit while displaying the white screen. The worker can visually confirm any abnormal operation of the main control unit and the sub-control unit.
 好ましくは、警報を報知するためのブザーを有し、前記ブザーは、前記副制御部が前記主制御部の動作異常を検出すると前記警報を報知し、前記主制御部が前記副制御部の動作異常を検出すると前記警報を報知することを特徴とする。
 上記構成によれば、主制御部と副制御部のいずれが異常動作しても、ブザーにより警報を報知できるので、医療従事者は主制御部と副制御部のいずれが異常動作をしても聴覚で確認することができる。
Preferably, a buzzer for notifying the alarm is provided, and the buzzer notifies the alarm when the sub control unit detects an operation abnormality of the main control unit, and the main control unit operates the sub control unit. When an abnormality is detected, the alarm is notified.
According to the above configuration, even if either the main control unit or the sub control unit operates abnormally, an alarm can be notified by the buzzer, so that the medical worker can operate either the main control unit or the sub control unit abnormally. It can be confirmed by hearing.
 好ましくは、前記バッテリの充電電圧異常を監視するバッテリ監視部を有し、前記温度センサは、前記バッテリ監視部に配置されていることを特徴とする。
 上記構成によれば、温度センサは、前記バッテリ監視部に配置されているものを用いるので、温度センサを別部品として搭載する必要が無いので、部品点数の低減が図れる。
Preferably, a battery monitoring unit that monitors a charging voltage abnormality of the battery is provided, and the temperature sensor is arranged in the battery monitoring unit.
According to the said structure, since the temperature sensor used in the said battery monitoring part is used, since it is not necessary to mount a temperature sensor as another component, reduction of a number of parts can be aimed at.
 好ましくは、前記医療用ポンプの本体の上部分には、前記表示部と、操作ボタンを有する操作パネル部が配置され、前記医療用ポンプの本体の下部分は、前記薬剤を送液するための送液部材を配置する領域であることを特徴とする。
 上記構成によれば、医療従事者は、本体の上部分の表示部の情報を確認しながら、医療用ポンプによる薬剤の送液作業を行うことができる。そして、医療従事者は、本体の上部分の表示部の情報を確認しながら、操作パネル部の操作ボタンを操作することができる。
Preferably, the display unit and an operation panel unit having operation buttons are arranged on an upper part of the main body of the medical pump, and a lower part of the main body of the medical pump is used for feeding the medicine. It is a region where a liquid feeding member is arranged.
According to the said structure, the medical worker can perform the liquid feeding operation | movement of the chemical | medical agent by a medical pump, confirming the information of the display part of the upper part of a main body. Then, the medical worker can operate the operation buttons on the operation panel unit while confirming the information on the display unit on the upper part of the main body.
 本発明は、輸液ポンプのような医療用ポンプが患者に対して薬剤を送液する際の安全性を確保することができ、コストダウンが図れる医療用ポンプを提供することができる。 The present invention can provide a medical pump that can ensure safety when a medical pump such as an infusion pump delivers a drug to a patient and can reduce costs.
本発明の医療用ポンプの好ましい実施形態である輸液ポンプを示す斜視図。The perspective view which shows the infusion pump which is preferable embodiment of the medical pump of this invention. 図1に示す輸液ポンプをW方向から見た図。The figure which looked at the infusion pump shown in FIG. 1 from the W direction. 輸液ポンプの開閉カバーを開いた状態を示す斜視図。The perspective view which shows the state which opened the opening-and-closing cover of the infusion pump. 輸液ポンプの電気的な構成例を示す図。The figure which shows the electrical structural example of an infusion pump. 輸液ポンプの動作例を示すフロー図。The flowchart which shows the operation example of an infusion pump. 輸液ポンプのフィンガ動作を示す図。The figure which shows the finger operation | movement of an infusion pump.
 以下に、本発明の好ましい実施形態を、図面を参照して詳しく説明する。尚、以下に述べる実施の形態は、本発明の好適な具体例であるから、技術的に好ましい種々の限定が付されているが、本発明の範囲は、以下の説明において特に本発明を限定する旨の記載がない限り、これらの態様に限られるものではない。
 図1は、本発明の医療用ポンプの好ましい実施形態である輸液ポンプを示す斜視図である。図2は、図1に示す輸液ポンプをW方向から見た図である。
Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the drawings. The embodiments described below are preferred specific examples of the present invention, and thus various technically preferable limitations are given. However, the scope of the present invention is particularly limited in the following description. Unless otherwise stated, the present invention is not limited to these embodiments.
FIG. 1 is a perspective view showing an infusion pump which is a preferred embodiment of the medical pump of the present invention. FIG. 2 is a view of the infusion pump shown in FIG. 1 as viewed from the W direction.
 図1と図2に示す輸液ポンプ1は、医療用ポンプの一例である。この輸液ポンプ1は、例えば集中治療室(ICU、CCU、NICU)等で使用され、患者に対して、例えば抗がん剤、麻酔剤、化学療法剤、輸血等、栄養剤等の薬剤(薬液ともいう)の微量注入処置を、高い精度で比較的長時間行うことに用いられる微量持続注入ポンプである。この輸液ポンプ1は、例えば薬剤ライブラリから使用する薬剤を選択して、その選択した薬剤を送液するために用いられる。この薬剤ライブラリは、薬剤ライブラリデータベース(DB)において、予め登録された薬剤名を含む薬剤の投与設定群である薬剤情報である。医療従事者は、この薬剤ライブラリを用いることにより、複雑な投与設定をその都度行わなくても良く、薬剤の選択および薬剤の設定が図れる。 The infusion pump 1 shown in FIGS. 1 and 2 is an example of a medical pump. The infusion pump 1 is used, for example, in an intensive care unit (ICU, CCU, NICU) or the like, and for a patient, for example, an anticancer agent, an anesthetic agent, a chemotherapeutic agent, a blood transfusion, etc. This is a micro continuous infusion pump used for performing microinjection treatment (also referred to as)) for a relatively long time with high accuracy. This infusion pump 1 is used, for example, for selecting a drug to be used from a drug library and feeding the selected drug. This drug library is drug information which is a drug administration setting group including drug names registered in advance in the drug library database (DB). By using this drug library, a medical worker does not have to perform complicated administration settings each time, and can select a drug and set a drug.
 図2に示すように、輸液ポンプ1は、薬剤171を充填した薬剤バッグ170から、クレンメ179と輸液チューブ200と留置針172を介して、患者Pに対して正確に送液することができる。薬剤は輸液剤ともいう。輸液チューブは輸液ラインともいう。
 輸液ポンプ1は、本体カバー2と取手2Tを有しており、取手2TはN方向に伸ばしたりT方向に収納したりすることができる。この本体カバー2は、本体ともいい、耐薬品性を有する成型樹脂材料により一体成型されており、仮に薬剤等がかかっても輸液ポンプ1の内部に侵入するのを防ぐことができる防滴処理構造を有している。このように、本体カバー2が防滴処理構造を有しているのは、上方に配置されている薬剤バッグ170内の薬剤171がこぼれ落ちたり、周辺で用いる消毒液等が飛散して付着することがあるためである。
As shown in FIG. 2, the infusion pump 1 can accurately deliver liquid to the patient P from the medicine bag 170 filled with the medicine 171 via the clamp 179, the infusion tube 200, and the indwelling needle 172. The drug is also called an infusion. An infusion tube is also called an infusion line.
The infusion pump 1 has a main body cover 2 and a handle 2T, and the handle 2T can be extended in the N direction or stored in the T direction. The main body cover 2 is also called a main body, and is integrally formed of a molded resin material having chemical resistance, and can be prevented from entering the infusion pump 1 even if a drug or the like is applied. have. As described above, the main body cover 2 has the drip-proof treatment structure because the medicine 171 in the medicine bag 170 disposed above spills out or disinfects the disinfecting liquid used in the vicinity. Because there is.
 まず、輸液ポンプ1の本体カバー2に配置された要素について説明する。
 図1と図2に示すように、本体カバー2の上部分2Aには、表示部3と、操作パネル部4が配置されている。表示部3は、画像表示装置であり、例えばカラー液晶表示装置を用いている。この表示部3は、日本語表記による情報表記だけでなく、必要に応じて複数の外国語による情報の表示を行うことができる。表示部3は、本体カバー2の上部分2Aの左上位置であって、開閉カバー5の上側に配置されている。本体カバー2の上部分2Aは、本体カバー2の上半分の部分である。本体カバー2の下部分2Bは、本体カバー2の下半分の部分である。
 輸液ポンプ1の本体カバー2の上部分2Aには、情報を表示する表示部3と、複数の操作ボタンを有する操作パネル部4が配置され、輸液ポンプ1の本体カバー2の下部分2Bは、薬剤を送液するための送液部材である輸液チューブ200を配置する領域である。これにより、医療従事者は、本体カバー2の上部分2Aの表示部3の情報を確認しながら、輸液ポンプ1による薬剤の送液作業を行うことができる。そして、医療従事者は、本体カバー2の上部分2Aの表示部3の情報を確認しながら、操作パネル部4の操作ボタンを操作することができる。このため、輸液ポンプ1の操作性が良好である。
First, the elements disposed on the main body cover 2 of the infusion pump 1 will be described.
As shown in FIGS. 1 and 2, a display unit 3 and an operation panel unit 4 are arranged on the upper portion 2 </ b> A of the main body cover 2. The display unit 3 is an image display device, and uses, for example, a color liquid crystal display device. This display unit 3 can display not only information notation in Japanese but also information in a plurality of foreign languages as required. The display unit 3 is disposed on the upper left side of the upper portion 2 </ b> A of the main body cover 2 and above the opening / closing cover 5. The upper portion 2 </ b> A of the main body cover 2 is an upper half portion of the main body cover 2. The lower part 2 </ b> B of the main body cover 2 is a lower half part of the main body cover 2.
A display portion 3 for displaying information and an operation panel portion 4 having a plurality of operation buttons are arranged on the upper portion 2A of the body cover 2 of the infusion pump 1, and a lower portion 2B of the body cover 2 of the infusion pump 1 is This is a region where an infusion tube 200 which is a liquid feeding member for feeding a medicine is arranged. Thereby, the medical worker can perform the liquid feeding operation of the medicine by the infusion pump 1 while confirming the information on the display unit 3 of the upper portion 2A of the main body cover 2. Then, the medical staff can operate the operation buttons on the operation panel unit 4 while checking the information on the display unit 3 of the upper portion 2A of the main body cover 2. For this reason, the operability of the infusion pump 1 is good.
 図2では、表示部3には、一例として薬剤投与の予定量(mL)の表示欄3B、薬剤投与の積算量(mL)の表示欄3C、充電履歴の表示欄3D、流量(mL/h)の表示欄3E等が表示されているが、図1に示す表示部3ではこれらの表示内容の図示は、図面の簡単化のために省略している。表示部3は、この他に警告メッセージを表示することもできる。また、表示部3は、LED(発光ダイオード)のバックライトを点灯することで、例えば黄色の表示画面から白色の表示画面に表示変更することができる。
 操作パネル部4は、本体カバー2の上部分2Aにおいて表示部3の右側に配置され、操作パネル部4には、操作ボタンとしては、図示例では、例えばパイロットランプ4A、早送りスイッチボタン4B、開始スイッチボタン4C、停止スイッチボタン4D、メニュー選択ボタン4E、電源スイッチ4F等が配置されている。
In FIG. 2, for example, the display unit 3 includes a display column 3B for a scheduled dose (mL) of drug administration, a display column 3C for an accumulated dose (mL) of drug administration, a display column 3D for a charge history, and a flow rate (mL / h). In the display section 3 shown in FIG. 1, illustration of these display contents is omitted for simplification of the drawing. The display unit 3 can also display a warning message. The display unit 3 can change the display from, for example, a yellow display screen to a white display screen by turning on a backlight of an LED (light emitting diode).
The operation panel unit 4 is disposed on the right side of the display unit 3 in the upper part 2A of the main body cover 2, and the operation panel unit 4 includes, for example, a pilot lamp 4A, a fast-forward switch button 4B, and a start button as illustrated in FIG. A switch button 4C, a stop switch button 4D, a menu selection button 4E, a power switch 4F, and the like are arranged.
 図1に示すように、本体カバー2の下部分2Bには、蓋部材としての開閉カバー5が回転軸5Aを中心として、R方向に開閉可能に設けられている。開閉カバー5は、X方向に沿って長く形成されている板状の蓋部材である。チューブ装着部50と送液駆動部60は、開閉カバー5の内側に配置されている。このチューブ装着部50には、例えば軟質塩化ビニル等の可撓性の熱可塑性樹脂製の輸液チューブ200をセットして、この開閉カバー5を閉じることで、輸液チューブ200は、チューブ装着部50において、X方向(T方向)に沿って水平に装着できる。なお、図1と図2におけるX方向、Y方向、Z方向は互いに直交しており、Z方向は上下方向である。X方向は、送液方向であるT方向と平行であり輸液ポンプ1の左右方向である。Y方向は、輸液ポンプ1の前後方向である。 As shown in FIG. 1, an opening / closing cover 5 as a lid member is provided on the lower portion 2B of the main body cover 2 so as to be openable and closable in the R direction around the rotation shaft 5A. The open / close cover 5 is a plate-like lid member that is formed long along the X direction. The tube mounting part 50 and the liquid feeding drive part 60 are disposed inside the opening / closing cover 5. An infusion tube 200 made of a flexible thermoplastic resin such as soft vinyl chloride is set in the tube mounting portion 50, and the infusion tube 200 is connected to the tube mounting portion 50 by closing the open / close cover 5. , And can be mounted horizontally along the X direction (T direction). Note that the X direction, the Y direction, and the Z direction in FIGS. 1 and 2 are orthogonal to each other, and the Z direction is the vertical direction. The X direction is parallel to the T direction, which is the liquid feeding direction, and is the left-right direction of the infusion pump 1. The Y direction is the front-rear direction of the infusion pump 1.
 図3は、図1と図2に示す輸液ポンプ1の開閉カバー5を開いて、輸液チューブ200を装着するためのチューブ装着部50を示す斜視図である。
 図3に示すように、チューブ装着部50と送液駆動部60は、輸液ポンプ1の本体下部1B側に設けられており、チューブ装着部50と送液駆動部60は、表示部3と操作パネル部4の下部においてX方向に沿って設けられている。チューブ装着部50は、図2に示すように開閉カバー5を、回転軸5Aを中心としてCR方向に閉じると開閉カバー5により覆うことができる。
FIG. 3 is a perspective view showing a tube mounting portion 50 for opening the opening / closing cover 5 of the infusion pump 1 shown in FIGS. 1 and 2 and mounting the infusion tube 200.
As shown in FIG. 3, the tube mounting part 50 and the liquid feeding drive part 60 are provided on the main body lower part 1B side of the infusion pump 1, and the tube mounting part 50 and the liquid feeding drive part 60 are operated with the display part 3. A lower portion of the panel portion 4 is provided along the X direction. As shown in FIG. 2, the tube mounting portion 50 can cover the open / close cover 5 with the open / close cover 5 when the open / close cover 5 is closed in the CR direction around the rotation shaft 5A.
 医療従事者は、本体カバー2の上部分2Aの表示部3の情報を確認しながら、チューブ装着部50への輸液チューブ200の装着を行って、開閉カバー5を閉じることができる。そして、医療従事者は、本体カバー2の上部分2Aの表示部3の情報を確認しながら、操作パネル部4の操作ボタンを操作することができる。これにより、医療現場において、輸液ポンプ1の操作性を向上することができる。
 図3に示すように、チューブ装着部50は、気泡センサ51と、上流閉塞センサ52と、下流閉塞センサ53と、チューブクランプ部270と、右側位置の第1輸液チューブガイド部54と左側位置の第2輸液チューブガイド部55を有している。
A medical worker can close the open / close cover 5 by attaching the infusion tube 200 to the tube attachment portion 50 while confirming information on the display portion 3 of the upper portion 2 </ b> A of the main body cover 2. Then, the medical staff can operate the operation buttons on the operation panel unit 4 while checking the information on the display unit 3 of the upper portion 2A of the main body cover 2. Thereby, in the medical field, the operativity of the infusion pump 1 can be improved.
As shown in FIG. 3, the tube mounting portion 50 includes a bubble sensor 51, an upstream blockage sensor 52, a downstream blockage sensor 53, a tube clamp portion 270, a first infusion tube guide portion 54 at the right side position, and a left side position. A second infusion tube guide portion 55 is provided.
 図3に示すように、チューブ装着部50の付近には、輸液チューブ200をセットする際に、正しい送液方向であるT方向を明確に表示するための輸液チューブ設定方向表示部150が設けられている。この輸液チューブ設定方向表示部150は、例えば複数の矢印151により構成されている。輸液チューブ設定方向表示部150は、例えばチューブ装着部50の下部に直接印刷しても良いし、シール状の部材に印刷したものをチューブ装着部50の下部に貼り付けても良い。輸液チューブ設定方向表示部150は、開閉カバー5の内側にセットされた輸液チューブ200による薬剤171の正しい方向の送液方向(T方向)を明示するために配置されている。
 これにより、医療従事者が、図3の開閉カバー5をCS方向に開けて、チューブ装着部50を開放して、このチューブ装着部50に対して輸液チューブ200を装着する際に、輸液チューブ200による薬剤の送液方向であるT方向を明示できる。このため、医療従事者が、誤って輸液チューブ200を逆方向に装着してしまうことを確実に防ぐことができる。
As shown in FIG. 3, an infusion tube setting direction display unit 150 for clearly displaying the T direction that is the correct liquid feeding direction when the infusion tube 200 is set is provided in the vicinity of the tube mounting unit 50. ing. The infusion tube setting direction display unit 150 includes, for example, a plurality of arrows 151. The infusion tube setting direction display unit 150 may be printed directly on the lower part of the tube mounting part 50, for example, or may be printed on a seal-like member and attached to the lower part of the tube mounting part 50. The infusion tube setting direction display unit 150 is arranged to clearly indicate the liquid feeding direction (T direction) in the correct direction of the medicine 171 by the infusion tube 200 set inside the opening / closing cover 5.
Accordingly, when the medical staff opens the opening / closing cover 5 of FIG. 3 in the CS direction, opens the tube mounting portion 50, and mounts the infusion tube 200 on the tube mounting portion 50, the infusion tube 200 It is possible to clearly indicate the T direction, which is the direction of drug delivery. For this reason, it can prevent reliably that a medical worker will attach the infusion tube 200 by the reverse direction accidentally.
 次に、図3に示す開閉カバー5の構造例を説明する。
 図3に示すように、開閉カバー5は、輸液ポンプ1を軽量化するために、薄い成型樹脂部材により作られている板状の部材である。これにより、開閉カバー5の重量を軽減でき、構造を簡単化することができる。開閉カバー5は、チューブ装着部50を、回転軸5Aを中心としてCS方向とCR方向に沿って開閉可能に覆うことができるようにするために、2つのヒンジ部2H、2Hにより本体カバー2の本体下部2Bに対して支持されている。2つのヒンジ部2H、2Hは、第1フック部材5Dと第2フック部材5Eにそれぞれ対応して配置されている。
Next, a structural example of the opening / closing cover 5 shown in FIG. 3 will be described.
As shown in FIG. 3, the open / close cover 5 is a plate-like member made of a thin molded resin member in order to reduce the weight of the infusion pump 1. Thereby, the weight of the opening / closing cover 5 can be reduced, and the structure can be simplified. The opening / closing cover 5 has two hinge portions 2H and 2H that allow the tube mounting portion 50 to be covered so as to be openable and closable along the CS direction and the CR direction about the rotation shaft 5A. It is supported with respect to the main body lower part 2B. The two hinge portions 2H and 2H are arranged corresponding to the first hook member 5D and the second hook member 5E, respectively.
 図2と図3に示すように、開閉カバー5の表面側には、右上部分に開閉操作レバー260が設けられている。開閉カバー5の内面側には、輸液チューブ押さえ部材500と、第1フック部材5Dと第2フック部材5Eが設けられている。この輸液チューブ押さえ部材500は、X方向に沿って長く矩形状かつ面状の突出部として配置されており、輸液チューブ押さえ部材500は、送液駆動部60に対面する位置にある。輸液チューブ押さえ部材500は、送液駆動部60に沿ってX方向に平坦面を有しており、輸液チューブ押さえ部材500は、開閉カバー5をCR方向に閉じることで、送液駆動部60との間で輸液チューブ200の一部分を押し付けて挟むようになっている。
 医療従事者は、表示部3に表示されている表示内容を確認しながら、輸液チューブ200を輸液ポンプ1の本体の下半分の部分に水平方向に沿ってセットでき、輸液チューブ200がチューブ装着部50にセットされた後に、開閉カバー5は輸液チューブ200を覆うことができる。
As shown in FIGS. 2 and 3, an opening / closing operation lever 260 is provided at the upper right portion on the surface side of the opening / closing cover 5. On the inner surface side of the opening / closing cover 5, an infusion tube pressing member 500, a first hook member 5D, and a second hook member 5E are provided. The infusion tube pressing member 500 is disposed as a long rectangular and planar protrusion along the X direction, and the infusion tube pressing member 500 is in a position facing the liquid feeding drive unit 60. The infusion tube pressing member 500 has a flat surface in the X direction along the liquid feeding drive unit 60, and the infusion tube pressing member 500 closes the opening / closing cover 5 in the CR direction, A part of the infusion tube 200 is pressed between them.
The medical worker can set the infusion tube 200 on the lower half of the body of the infusion pump 1 along the horizontal direction while confirming the display content displayed on the display unit 3, and the infusion tube 200 is connected to the tube mounting portion. After being set to 50, the opening / closing cover 5 can cover the infusion tube 200.
 図3に示すように、第1フック部材5Dと第2フック部材5Eは、本体下部1B側の固定部分1D、1Eに対してそれぞれ機械的に同時に掛かることにより、開閉カバー5は、図2に示すように、本体下部1Bのチューブ装着部50を閉鎖した状態に保持する。この第1フック部材5Dと第2フック部材5Eと、本体下部1B側の固定部分1D、1Eは、開閉カバー5のダブルフック構造部300を構成している。 As shown in FIG. 3, the first hook member 5D and the second hook member 5E are mechanically simultaneously engaged with the fixing portions 1D and 1E on the lower body 1B side, so that the open / close cover 5 is As shown, the tube mounting part 50 of the main body lower part 1B is held in a closed state. The first hook member 5D, the second hook member 5E, and the fixing portions 1D, 1E on the main body lower part 1B side constitute a double hook structure portion 300 of the opening / closing cover 5.
 図3に示すチューブクランプ部270は、開閉カバー5を閉じることにより、輸液チューブ200の途中部分をクランプして閉塞させる。チューブクランプ部270は、左側の固定部分1Eの近傍であって、左側の第2フック部材5Eに対応する位置に配置されている。医療従事者が輸液チューブ200をX方向に水平にセットして、医療従事者が開閉カバー5をCR方向に閉じると、チューブクランプ部270は、輸液チューブ200の途中の一部分を閉塞できる。 The tube clamp part 270 shown in FIG. 3 clamps and closes the middle part of the infusion tube 200 by closing the open / close cover 5. The tube clamp portion 270 is disposed in the vicinity of the left fixed portion 1E and at a position corresponding to the left second hook member 5E. When the medical worker sets the infusion tube 200 horizontally in the X direction and the medical worker closes the opening / closing cover 5 in the CR direction, the tube clamp portion 270 can block a part of the infusion tube 200 in the middle.
 図3に示すように、第1輸液チューブガイド部54は、本体下部1Bおいて向かって右側部分に設けられ、第2輸液チューブガイド部55は、本体下部1Bにおいて向かって左側部分に設けられている。第1輸液チューブガイド部54は、輸液チューブ200の上流側200Aをはめ込むことで保持でき、第2輸液チューブガイド部55は、輸液チューブ200の下流側200Bをはめ込むことで保持でき、輸液チューブ200をX方向に沿って水平方向に保持するようになっている。このように、水平方向に保持された輸液チューブ200は、気泡センサ51と、上流閉塞センサ52と、送液駆動部60と、下流閉塞センサ53と、そしてチューブクランプ部270に沿って、T方向に沿ってはめ込んで固定される。 As shown in FIG. 3, the first infusion tube guide portion 54 is provided on the right side of the main body lower portion 1B, and the second infusion tube guide portion 55 is provided on the left side of the main body lower portion 1B. Yes. The first infusion tube guide portion 54 can be held by fitting the upstream side 200A of the infusion tube 200, and the second infusion tube guide portion 55 can be held by fitting the downstream side 200B of the infusion tube 200, and the infusion tube 200 can be held. It is held in the horizontal direction along the X direction. Thus, the infusion tube 200 held in the horizontal direction is in the T direction along the bubble sensor 51, the upstream block sensor 52, the liquid feed drive unit 60, the downstream block sensor 53, and the tube clamp unit 270. It is fixed by fitting along.
 図3に示すように、第2輸液チューブガイド部55は、輸液チューブ200の下流側200Bの一部分を着脱可能に挟んで保持するために、本体下部1Bの側面部分1Sに形成された溝部分である。第1輸液チューブガイド部54と第2輸液チューブガイド部55は、輸液チューブ200を開閉カバー5とチューブ装着部50との間に挟み込んで潰してしまうことが無いように、チューブ装着部50内に確実に装着できる。 As shown in FIG. 3, the second infusion tube guide portion 55 is a groove portion formed in the side surface portion 1 </ b> S of the main body lower portion 1 </ b> B in order to detachably hold a part of the downstream side 200 </ b> B of the infusion tube 200. is there. The first infusion tube guide portion 54 and the second infusion tube guide portion 55 are provided in the tube attachment portion 50 so that the infusion tube 200 is not sandwiched between the opening / closing cover 5 and the tube attachment portion 50 and crushed. Can be installed securely.
 図3に示す気泡センサ51は、輸液チューブ200内に生じる気泡(空気)を検出するセンサであり、例えば気泡センサ51は、軟質塩化ビニルなどの輸液チューブ200の外側から、輸液チューブ200内に流れる薬剤中に含まれる気泡を監視する超音波センサである。超音波センサの超音波発信部から発生する超音波を輸液チューブ200内に流れる薬剤に当てることで、薬剤における超音波の透過率と、気泡における超音波の透過率とが異なることから、超音波受信部は、その透過率の差を検出して気泡の有無を監視する。気泡センサ51は、押し当て部材320と受け部材330を有している。超音波発振部は押し当て部材320に配置されている。超音波受信部は受け部材330に配置されている。 The bubble sensor 51 shown in FIG. 3 is a sensor that detects bubbles (air) generated in the infusion tube 200. For example, the bubble sensor 51 flows into the infusion tube 200 from the outside of the infusion tube 200 such as soft vinyl chloride. It is an ultrasonic sensor that monitors bubbles contained in a medicine. By applying ultrasonic waves generated from the ultrasonic wave transmitter of the ultrasonic sensor to the drug flowing in the infusion tube 200, the ultrasonic wave transmittance in the drug and the ultrasonic wave transmittance in the bubbles are different. The receiving unit monitors the presence or absence of bubbles by detecting the difference in transmittance. The bubble sensor 51 has a pressing member 320 and a receiving member 330. The ultrasonic oscillator is disposed on the pressing member 320. The ultrasonic wave receiver is disposed on the receiving member 330.
 図3に示す上流閉塞センサ52は、輸液チューブ200の上流側200Aにおいて輸液チューブ200内が閉塞しているかどうかを検出するセンサであり、下流閉塞センサ53は、輸液チューブ200の下流側200Bにおいて輸液チューブ200内が閉塞しているかどうかを検出するセンサである。上流閉塞センサ52と下流閉塞センサ53は、同じ構成である。輸液チューブ200が閉塞する場合としては、例えば送液しようとする薬剤の粘度が高いか、薬剤の濃度が高い等の場合である。
 図3に示すように、開閉カバー5の内面側には、上流閉塞センサ52と下流閉塞センサ53の対応する位置に、それぞれ押圧部材452、453が設けられている。医療従事者が、図3に示すようにチューブ装着部50に輸液チューブ200をセットした後に、図2に示すように開閉カバー5を閉じると、開閉カバー5側の押圧部材452と押圧部材453が輸液チューブ200の一部分を上流側閉塞センサ52と下流側閉塞センサ53側にそれぞれ押し当てることができる。このため、直径が異なる複数種類の輸液チューブ200の内の何れのサイズの輸液チューブ200が輸液ポンプ1に装着されても、開閉カバー5を閉じると上流側閉塞センサ52と下流側閉塞センサ53は、輸液チューブ200の閉塞状態を検出できる。
The upstream blockage sensor 52 shown in FIG. 3 is a sensor that detects whether or not the inside of the infusion tube 200 is blocked on the upstream side 200A of the infusion tube 200, and the downstream blockage sensor 53 is an infusion solution on the downstream side 200B of the infusion tube 200. It is a sensor that detects whether or not the inside of the tube 200 is closed. The upstream blockage sensor 52 and the downstream blockage sensor 53 have the same configuration. The case where the infusion tube 200 is blocked is, for example, a case where the viscosity of the medicine to be delivered is high or the concentration of the medicine is high.
As shown in FIG. 3, pressing members 452 and 453 are provided on the inner surface side of the opening / closing cover 5 at positions corresponding to the upstream closing sensor 52 and the downstream closing sensor 53, respectively. When the medical worker sets the infusion tube 200 in the tube mounting portion 50 as shown in FIG. 3 and then closes the opening and closing cover 5 as shown in FIG. 2, the pressing member 452 and the pressing member 453 on the opening and closing cover 5 side A part of the infusion tube 200 can be pressed against the upstream blockage sensor 52 and the downstream blockage sensor 53 side, respectively. For this reason, even if the infusion tube 200 of any size among the plural types of infusion tubes 200 having different diameters is attached to the infusion pump 1, when the open / close cover 5 is closed, the upstream side occlusion sensor 52 and the downstream side occlusion sensor 53 are The occlusion state of the infusion tube 200 can be detected.
 図4は、輸液ポンプ1の電気的な構成例を示している。
 図4に示すように、輸液ポンプ1は、主制御部100と副制御部400を有している。送液駆動部60は、駆動モータ61と、この駆動モータ61により回転駆動される複数個の偏心カムを有するカム構造体62と、このカム構造体62の各カム(偏心カム62A~62F)により移動される複数のフィンガを有するフィンガ63を有している。
 カム構造体62は、複数の偏心カム、例えば複数の偏心カム62A~62Fを有しており、フィンガ構造体63は、複数の偏心カム62A~62Fに対応して複数のフィンガ63A~63Fを有している。複数の偏心カム62A~62Fは互いに位相差を付けて配列されており、カム構造体62は、駆動モータ61の出力軸61Aに連結されている。
 こうして、駆動モータ61の出力軸61Aが回転すると出力軸61Aに軸支されたカム構造体62が回転し、複数のフィンガ63A~63Fを順次Y方向に所定ストローク分(上死点と下死点との距離分)進退させることで、輸液チューブ200はT方向に沿って開閉カバー5の輸液チューブ押さえ部材500に対して押し付けられる。このため、輸液チューブ200内の薬剤は、T方向に送液することができる。
FIG. 4 shows an electrical configuration example of the infusion pump 1.
As shown in FIG. 4, the infusion pump 1 has a main control unit 100 and a sub control unit 400. The liquid feeding drive unit 60 includes a drive motor 61, a cam structure 62 having a plurality of eccentric cams that are rotationally driven by the drive motor 61, and cams (eccentric cams 62A to 62F) of the cam structure 62. A finger 63 having a plurality of fingers to be moved is provided.
The cam structure 62 has a plurality of eccentric cams, for example, a plurality of eccentric cams 62A to 62F, and the finger structure 63 has a plurality of fingers 63A to 63F corresponding to the plurality of eccentric cams 62A to 62F. is doing. The plurality of eccentric cams 62A to 62F are arranged with a phase difference from each other, and the cam structure 62 is connected to the output shaft 61A of the drive motor 61.
Thus, when the output shaft 61A of the drive motor 61 rotates, the cam structure 62 supported by the output shaft 61A rotates, and the plurality of fingers 63A to 63F are sequentially moved in the Y direction by a predetermined stroke (top dead center and bottom dead center). The infusion tube 200 is pressed against the infusion tube holding member 500 of the opening / closing cover 5 along the T direction. For this reason, the medicine in infusion tube 200 can be sent in the T direction.
 図4に示す副制御部400の指令により、駆動モータ61の出力軸61Aが回転すると、複数のフィンガ63A~63Fが順番にY方向に所定ストローク分進退することで、輸液チューブ200はT方向に沿って開閉カバー5の輸液チューブ押さえ部材500に対して押し付けられる。このため、輸液チューブ200内の薬剤は、T方向に送液することができる。すなわち、複数のフィンガ63A~63Fが個別駆動されることで、複数のフィンガ63A~63Fが輸液チューブ200の外周面をT方向に沿って順次押圧して輸液チューブ200内の薬剤の送液を行う。このように、副制御部400が、複数のフィンガ63A~63Fの蠕動運動を制御することにより、フィンガ63A~63Fを順次前後進させ、あたかも波動が進行するようにして、輸液チューブ200の閉塞点をT方向に移動させることで、輸液チューブ200をしごいて薬剤を移送する。 When the output shaft 61A of the drive motor 61 rotates in response to a command from the sub-control unit 400 shown in FIG. 4, the plurality of fingers 63A to 63F sequentially advance and retract by a predetermined stroke in the Y direction, so that the infusion tube 200 moves in the T direction. Along the infusion tube pressing member 500 of the opening / closing cover 5. For this reason, the medicine in infusion tube 200 can be sent in the T direction. That is, when the plurality of fingers 63A to 63F are individually driven, the plurality of fingers 63A to 63F sequentially press the outer peripheral surface of the infusion tube 200 along the T direction to feed the medicine in the infusion tube 200. . In this way, the sub-control unit 400 controls the peristaltic motion of the plurality of fingers 63A to 63F, thereby causing the fingers 63A to 63F to move forward and backward in sequence, so that the wave travels, so that the blocking point of the infusion tube 200 is increased. Is moved in the T direction to squeeze the infusion tube 200 and transfer the medicine.
 上述したように、輸液ポンプ1は、主制御部100と副制御部400を有している。主制御部100は第1制御部であり、副制御部400は第2制御部である。主制御部100はCPU(中央制御部)チップを採用しているが、副制御部400としては好ましくはFPGA(Field-Programmable Gate Array)を採用している。このFPGAは、ユーザが希望する論理機能をユーザ自らのコンピュータを使って短期間で実現できるデバイスであり、CPUに比べて安価である。
 主制御部100は、全体的な動作の制御を行うために、例えばワンチップのマイクロコンピュータを用いており、ROM(読み出し専用メモリ)101、RAM(ランダムアクセスメモリ)102、不揮発性メモリ103、そしてクロック104を有する。クロック104は、所定の操作により現在時刻の修正ができ、現在時刻の取得や、所定の送液作業の経過時間の計測、送液の速度制御の基準時間の計測等ができる。
As described above, the infusion pump 1 has the main control unit 100 and the sub control unit 400. The main control unit 100 is a first control unit, and the sub control unit 400 is a second control unit. The main control unit 100 employs a CPU (central control unit) chip, but the sub-control unit 400 preferably employs an FPGA (Field-Programmable Gate Array). The FPGA is a device that can realize a logic function desired by the user in a short period of time using the user's own computer, and is less expensive than a CPU.
The main control unit 100 uses, for example, a one-chip microcomputer to control the overall operation, and includes a ROM (Read Only Memory) 101, a RAM (Random Access Memory) 102, a non-volatile memory 103, and A clock 104 is included. The clock 104 can correct the current time by a predetermined operation, and can acquire the current time, measure the elapsed time of a predetermined liquid feeding operation, measure the reference time of liquid feeding speed control, and the like.
 図4に示す主制御部100と副制御部400は、電気的に接続されており、相互の監視と周辺要素の監視を行う。すなわち、主制御部100は、副制御部400の異常動作(例えば暴走動作)を監視するとともに、主制御部100に直接接続されている周辺要素の監視を行う。これに対して、副制御部400は、主制御部100の異常動作(例えば暴走動作)を監視するとともに、副制御部400に接続されている周辺要素の制御と監視を行う。
 図4に例示する主制御部100は、次の周辺要素に直接接続されている。主制御部100に直接接続されているのは、バッテリ監視部181と、電源コンバータ部112とバッテリ113である。
The main control unit 100 and the sub control unit 400 shown in FIG. 4 are electrically connected, and perform mutual monitoring and monitoring of peripheral elements. That is, the main control unit 100 monitors abnormal operations (for example, runaway operation) of the sub-control unit 400 and monitors peripheral elements directly connected to the main control unit 100. On the other hand, the sub control unit 400 monitors abnormal operations (for example, runaway operation) of the main control unit 100 and controls and monitors peripheral elements connected to the sub control unit 400.
The main control unit 100 illustrated in FIG. 4 is directly connected to the following peripheral elements. Directly connected to the main control unit 100 are a battery monitoring unit 181, a power converter unit 112, and a battery 113.
 この他に、主制御部100は、電源スイッチボタン4Fと電源切り替え用のスイッチ111、表示部ドライバ130、駆動モータ61、スピーカ131、ブザー132、ナースセンタ側の情報端末600に接続されている。このスイッチ111は、電源コンバータ部112とバッテリ113を切り換えることで、電源コンバータ部112とバッテリ113の一方から主制御部100に対して電源供給する。電源コンバータ部112は、コンセント114を介して商用交流電源115に接続されている。バッテリ113は、例えばリチウムイオン電池等の充放電可能な二次電池である。主制御部100は、充電指令信号CZを出して充電用のスイッチ199をスイッチオンすることで、電源コンバータ部112からバッテリ113に充電を行うことができる。主制御部100が、この充電指令信号CZを解除すれば、バッテリ113に充電を中止できる。
 また、主制御部100は、必要に応じて上流閉塞センサ52と下流閉塞センサ53にも接続されている。これにより、主制御部100は、輸液チューブ200内の閉塞状態の監視をもすることができる。
In addition, the main control unit 100 is connected to a power switch button 4F, a power switch 111, a display driver 130, a drive motor 61, a speaker 131, a buzzer 132, and an information terminal 600 on the nurse center side. This switch 111 supplies power to the main control unit 100 from one of the power converter unit 112 and the battery 113 by switching between the power converter unit 112 and the battery 113. The power converter unit 112 is connected to a commercial AC power source 115 via an outlet 114. The battery 113 is a rechargeable secondary battery such as a lithium ion battery. The main control unit 100 can charge the battery 113 from the power converter unit 112 by issuing a charge command signal CZ and turning on the charging switch 199. If the main control unit 100 cancels the charging command signal CZ, charging of the battery 113 can be stopped.
The main control unit 100 is also connected to an upstream blockage sensor 52 and a downstream blockage sensor 53 as necessary. Thereby, the main control unit 100 can also monitor the closed state in the infusion tube 200.
 図4の温度センサ180は、バッテリ監視部181内に内蔵されている。これにより、バッテリ監視部181とは別に温度センサを設ける必要が無いので、部品点数を減らすことができる。温度センサ180は、輸液ポンプ1のバッテリ113の動作時の温度を測定して、その温度測定結果を主制御部100に対して温度センサ値(A/D値)TSとして通知する。これにより、主制御部100は、バッテリ113の動作時の温度からバッテリ113の異常状態を検出することができる。バッテリ監視部181は、バッテリ監視用の集積回路であり、電源コンバータ部112とバッテリ113から得られる電圧値が予め定められた値の範囲内にあるかを監視して、主制御部100に監視信号QSを供給する。これにより、主制御部100はバッテリ113の充電電圧異常を監視することができるようになっている。 4 is incorporated in the battery monitoring unit 181. Thereby, it is not necessary to provide a temperature sensor separately from the battery monitoring unit 181, so that the number of parts can be reduced. The temperature sensor 180 measures the temperature when the battery 113 of the infusion pump 1 is operating, and notifies the main controller 100 of the temperature measurement result as a temperature sensor value (A / D value) TS. Thereby, main controller 100 can detect the abnormal state of battery 113 from the temperature during operation of battery 113. The battery monitoring unit 181 is an integrated circuit for battery monitoring, monitors whether the voltage values obtained from the power converter unit 112 and the battery 113 are within a predetermined value range, and monitors the main control unit 100. A signal QS is supplied. As a result, the main control unit 100 can monitor the charging voltage abnormality of the battery 113.
 図4に示す主制御部100と副制御部400の間には、ROM185が接続されている。また、副制御部400には、別のROM190が接続されている。これらのROM185、190は、半導体メモリに一種である、例えばフラッシュROM(Flash ROM)を用いており、データの消去と書き込みを自由に行うことができ、電源を切ってもデータの内容が消えない。ROM185には、例えば主制御部100が副制御部400の動作異常を検出するために主制御部100から副制御部400に書き込むための任意のデータが記憶されている。ROM190には、副制御部400を動作させるためのプログラムが記憶されている。 A ROM 185 is connected between the main control unit 100 and the sub control unit 400 shown in FIG. Further, another ROM 190 is connected to the sub-control unit 400. These ROMs 185 and 190 use a kind of semiconductor memory, for example, a flash ROM (Flash ROM). Data can be freely erased and written, and the data contents are not lost even when the power is turned off. . The ROM 185 stores arbitrary data for the main control unit 100 to write from the main control unit 100 to the sub control unit 400 in order to detect an abnormal operation of the sub control unit 400, for example. The ROM 190 stores a program for operating the sub control unit 400.
 図4に示すように、副制御部400は、表示部ドライバ130、エラー表示ランプ3W、スピーカ131、ブザー132、気泡センサ51、上流閉塞センサ52、下流閉塞センサ53、通信ポート140、操作パネル(操作ボタン)4と、そしてナースセンタ側の情報端末600に電気的に接続されており、これらの周辺要素の管理と制御を行っている。ナースセンタ側の情報端末600は、ナースセンタ650に置かれており、上述した表示部3、エラー表示ランプ3W、スピーカ131、ブザー132と同様の表示部3T、エラー表示ランプ3WT、スピーカ131T、ブザー132Tを有している。 As shown in FIG. 4, the sub-control unit 400 includes a display unit driver 130, an error display lamp 3W, a speaker 131, a buzzer 132, a bubble sensor 51, an upstream block sensor 52, a downstream block sensor 53, a communication port 140, an operation panel ( The operation button 4 is electrically connected to the information terminal 600 on the nurse center side, and these peripheral elements are managed and controlled. An information terminal 600 on the nurse center side is placed in the nurse center 650, and the display unit 3T, error display lamp 3WT, speaker 131T, buzzer similar to the display unit 3, error display lamp 3W, speaker 131, and buzzer 132 described above. 132T.
 図4の表示部ドライバ130は、主制御部100の指令あるいは副制御部400の指令により表示部3を駆動して、図2に例示する情報内容や警告メッセージを表示し、LED(発光ダイオード)のバックライトを点灯させる。エラー表示ランプ3Wは、主制御部100あるいは副制御部400のいずれかが故障した場合に、点灯する。スピーカ131は、主制御部100の指令あるいは副制御部400の指令により各種の警報内容を音声により告知することができる。ブザー132は、主制御部100の指令あるいは副制御部400の指令により各種の警報を音により告知することができる。 The display unit driver 130 in FIG. 4 drives the display unit 3 according to a command from the main control unit 100 or a command from the sub control unit 400, displays information contents and warning messages illustrated in FIG. 2, and LED (light emitting diode). Turn on the backlight. The error display lamp 3W is turned on when either the main control unit 100 or the sub control unit 400 fails. The speaker 131 can notify various alarm contents by voice according to a command from the main control unit 100 or a command from the sub-control unit 400. The buzzer 132 can notify various alarms by sound according to a command from the main control unit 100 or a command from the sub-control unit 400.
 図4において、気泡センサ51からの気泡検出信号S1と、上流閉塞センサ52からの輸液チューブ200の上流側が閉塞したことを示す上流閉塞信号S2と、そして下流閉塞センサ53からの輸液チューブ200の下流側が閉塞したことを示す下流閉塞信号S3は、副制御部400に供給される。上流閉塞センサ52と下流閉塞センサ53は、輸液回路の内圧が輸液ポンプ1内の設定圧を越えて、薬剤を送液できない状態を検出することができる。輸液回路の内圧が輸液ポンプ1内の設定圧を越える原因としては、輸液用の留置針や輸液チューブ200の詰まっている場合、輸液チューブ200がつぶれているまたは折れている場合、高粘度の薬剤を使用している場合等である。 In FIG. 4, the bubble detection signal S <b> 1 from the bubble sensor 51, the upstream block signal S <b> 2 indicating that the upstream side of the infusion tube 200 from the upstream block sensor 52 is blocked, and the downstream of the infusion tube 200 from the downstream block sensor 53. A downstream blocking signal S3 indicating that the side is blocked is supplied to the sub-control unit 400. The upstream blockage sensor 52 and the downstream blockage sensor 53 can detect a state in which the internal pressure of the infusion circuit exceeds the set pressure in the infusion pump 1 and the medicine cannot be delivered. The reason why the internal pressure of the infusion circuit exceeds the set pressure in the infusion pump 1 is that when the infusion needle for infusion or the infusion tube 200 is clogged, the infusion tube 200 is crushed or broken, a highly viscous drug This is the case when using.
 図4において、副制御部400は、通信ポート140を通じて、例えば、デスクトップコンピュータのようなコンピュータ141に対して双方向に通信可能である。このコンピュータ141は、薬剤データベース(DB)160に接続されており、薬剤データベース160に格納されている薬剤情報MFは、コンピュータ141を介して、副制御部400に取得して、副制御部400のROM101に記憶させることができる。副制御部400は、記憶した薬剤情報MFを基にして、例えば図2に示す表示部3には薬剤情報MF等を表示することができる。 4, the sub-control unit 400 can communicate bidirectionally with a computer 141 such as a desktop computer through the communication port 140. The computer 141 is connected to a drug database (DB) 160, and drug information MF stored in the drug database 160 is acquired by the sub-control unit 400 via the computer 141, and the sub-control unit 400 It can be stored in the ROM 101. The sub-control unit 400 can display the drug information MF and the like on the display unit 3 shown in FIG. 2, for example, based on the stored drug information MF.
 次に、図4と図5を参照して、輸液ポンプ1の動作例を説明する。図5は、輸液ポンプ1の動作例を示すフロー図である。
 医療従事者が、図5のステップST1において、図4に示す電源スイッチ4Fを押してスイッチオンすると、主制御部100と副制御部400が起動をして、相互の監視と周辺要素の監視を行う。すなわち、主制御部100は、副制御部400の異常動作(例えば暴走動作)を監視するとともに、主制御部100に直接接続された周辺要素の監視を行う。これに対して、副制御部400は、主制御部100の異常動作(例えば暴走動作)を監視するとともに、副制御部400に接続された周辺要素の動作制御と監視を行う。図4に示す副制御部400が送液駆動部60の駆動モータ61を作動することで、カム構造体62が輸液チューブ200を押圧することで、送液方向Tに沿って薬剤の送液を行う。
Next, an operation example of the infusion pump 1 will be described with reference to FIGS. 4 and 5. FIG. 5 is a flowchart showing an operation example of the infusion pump 1.
When the medical worker presses the power switch 4F shown in FIG. 4 to switch on in step ST1 of FIG. 5, the main control unit 100 and the sub control unit 400 are activated to perform mutual monitoring and monitoring of peripheral elements. . That is, the main control unit 100 monitors abnormal operations (for example, runaway operation) of the sub-control unit 400 and monitors peripheral elements directly connected to the main control unit 100. On the other hand, the sub-control unit 400 monitors the abnormal operation (for example, runaway operation) of the main control unit 100 and controls and monitors the peripheral elements connected to the sub-control unit 400. When the sub-control unit 400 shown in FIG. 4 operates the drive motor 61 of the liquid feeding drive unit 60, the cam structure 62 presses the infusion tube 200, thereby feeding the drug along the liquid feeding direction T. Do.
 (主制御部100の動作異常の監視)
 この薬剤の送液の際に、ステップST2では、副制御部400は、主制御部100の動作異常を、ウォッチドッグタイマ(WDT)により監視をする。主制御部100の動作異常は、この主制御部100に使用しているマイクロコンピュータが正常に動作していない場合に発生する異常である。そこで、副制御部400は、主制御部100が正常に動作しているか異常動作をしているかを、ウォッチドッグタイマというタイマによりチェックする。
(Monitoring of abnormal operation of main controller 100)
At the time of feeding the medicine, in step ST2, the sub-control unit 400 monitors an abnormal operation of the main control unit 100 by a watch dog timer (WDT). The abnormal operation of the main control unit 100 is an abnormality that occurs when the microcomputer used in the main control unit 100 is not operating normally. Therefore, the sub-control unit 400 checks whether the main control unit 100 is operating normally or abnormally using a timer called a watchdog timer.
 このウォッチドッグタイマは、主制御部100が正常に動作しているかどうかチェックする方法の1つである。ウォッチドッグタイマという正常な処理ルーチンでは、ウォッチドッグタイマは、ある一定時間内に命令によってリセットされるタイマを起動させておき、もしこの一定時間を経過してもタイマがリセットされていない場合には、プログラムが異常な処理ルーチンに入ったと判断し、割り込みを発生させることで、主制御部100の動作異常を検出する。例えば、副制御部400は、主制御部100に対して、例えばある命令を実行して予め定めた時間を経過しても再び同じ命令を実行するようにプログラミングしておき、実際に例えば予め定めた時間を経過してもこの命令が実行されなかった場合には、副制御部400は、主制御部100のハードウェアに異常が発生したと判断する。ただし、副制御部400は、主制御部100の動作を強制的にリセット状態にはしない。この理由としては、主制御部100は、副制御部400に対して上位の役割を果たしているが、副制御部400は、主制御部100のハードウェアに異常が発生したと判断したとしても、主制御部100が絶対に異常状態になっているとは限らないので、主制御部100はリセット状態にはしないが、ステップST3において示すような各種の対応処置を実行する。 This watchdog timer is one of the methods for checking whether the main control unit 100 is operating normally. In a normal processing routine called watchdog timer, the watchdog timer starts a timer that is reset by an instruction within a certain period of time, and if the timer has not been reset even after this certain period of time has elapsed. Then, it is determined that the program has entered an abnormal processing routine, and an interruption is generated to detect an abnormal operation of the main control unit 100. For example, the sub-control unit 400 is programmed to execute, for example, a certain command to the main control unit 100 so that the same command is executed again even after a predetermined time elapses. If the instruction is not executed even after a lapse of time, the sub-control unit 400 determines that an abnormality has occurred in the hardware of the main control unit 100. However, the sub control unit 400 does not forcibly reset the operation of the main control unit 100. For this reason, the main control unit 100 plays a higher role with respect to the sub control unit 400, but even if the sub control unit 400 determines that an abnormality has occurred in the hardware of the main control unit 100, Since the main control unit 100 is not necessarily in an abnormal state, the main control unit 100 does not enter the reset state, but executes various countermeasures as shown in step ST3.
 図5のステップST2では、図4に示す副制御部400は、主制御部100のハードウェアに異常が発生したと判断すると、ステップST3では、副制御部400は、図4の表示部ドライバ130に指令を出して、表示部ドライバ130は、表示部3において「主制御部100(CPU)エラー」を表示させる。この場合には、例えば、医療従事者に対する視認性を上げるために、表示部3の液晶表示装置の表示色は、例えば黄色画面から「白色画面」に変更され、この「白色画面」に「CPU Error」と表示させる。これにより、医療従事者は、通常の表示部3の表示色とは異なる「白色画面」でエラー表示を見ることになるので、主制御部100のエラーを容易にしかも確実に視認することができる。 In step ST2 of FIG. 5, when the sub control unit 400 shown in FIG. 4 determines that an abnormality has occurred in the hardware of the main control unit 100, in step ST3, the sub control unit 400 displays the display unit driver 130 of FIG. The display unit driver 130 causes the display unit 3 to display “main control unit 100 (CPU) error”. In this case, for example, the display color of the liquid crystal display device of the display unit 3 is changed from, for example, a yellow screen to a “white screen” in order to increase the visibility for the medical staff. “Error” is displayed. As a result, the medical staff sees the error display on a “white screen” different from the display color of the normal display unit 3, so that the error of the main control unit 100 can be easily and reliably visually recognized. .
 また、ステップST3では、副制御部400は、エラー表示ランプ3Wの赤LEDを、「赤点灯」させ、ブザー132を鳴動させ、駆動モータ61の動作を停止させて、薬剤の送液動作を停止する。また、必要に応じて、副制御部400は、スピーカ131を通じて、音声で「主制御部100(CPU)のエラー」を医療従事者に対して出すことで、ナースコール信号を発報する。
 このステップST3では、好ましくは、副制御部400は、ナースセンタ側の情報端末600に対しても「主制御部100(CPU)エラー」を医療従事者に対して通知する。これにより、表示部3の液晶表示装置の表示色は、バックライト点灯することで、例えば黄色画面から「白色画面」に変更され、この「白色画面」には「CPU Error」と表示させる。しかも、ステップST3では、副制御部400は、エラー表示ランプ3WTの赤LEDを「赤点灯」させ、ブザー132Tを鳴動させて、スピーカ131Tを通じて音声で「主制御部100(CPU)エラー」を医療従事者に対して出すことで、ナースコール信号を発報する。
In step ST3, the sub-control unit 400 turns on the red LED of the error display lamp 3W, turns on the buzzer 132, stops the operation of the drive motor 61, and stops the medicine feeding operation. To do. Further, if necessary, the sub-control unit 400 issues a nurse call signal by issuing a “main control unit 100 (CPU) error” to the medical staff through the speaker 131 by voice.
In this step ST3, preferably, the sub-control unit 400 notifies the medical staff of “main control unit 100 (CPU) error” also to the information terminal 600 on the nurse center side. Thereby, the display color of the liquid crystal display device of the display unit 3 is changed from, for example, a yellow screen to a “white screen” by turning on the backlight, and “CPU Error” is displayed on the “white screen”. Moreover, in step ST3, the sub-control unit 400 “red-lights” the red LED of the error display lamp 3WT, rings the buzzer 132T, and medically reports “main control unit 100 (CPU) error” by voice through the speaker 131T. A nurse call signal is issued by issuing to a worker.
 (副制御部400の動作異常の監視)
 一方、図5のステップST2において、図4に示す副制御部400は、主制御部100のハードウェアに異常が発生していないと判断すると、ステップST4に移る。ステップST4では、今度は主制御部100が、副制御部400の動作異常の監視を行う。
 主制御部100が、副制御部400の動作異常の監視する際には、主制御部100が、副制御部400のレジスタに毎回異なる任意のデータを、エラーチェックレジスタに書き込んで(WRITE)、そして主制御部100は副制御部400内のこのエラーチェックレジスタに書き込んだデータを読み出す(READ)。これにより、主制御部100は、書き込んだデータと読み出したデータを比較することでベリファイ(検査)して確認する。この任意のデータは、例えば図4に示すROM185に記憶されている。そして、主制御部100は、書き込んだデータと読み出したデータを比較することで、書き込んだデータと読み出したデータが異なっていれば、主制御部100は、副制御部400が動作異常しているものと判断する。
(Monitoring of abnormal operation of sub-control unit 400)
On the other hand, when the sub-control unit 400 shown in FIG. 4 determines that no abnormality has occurred in the hardware of the main control unit 100 in step ST2 of FIG. 5, the process proceeds to step ST4. In step ST4, the main control unit 100 now monitors the operation abnormality of the sub control unit 400.
When the main control unit 100 monitors the operation abnormality of the sub-control unit 400, the main control unit 100 writes arbitrary different data in the register of the sub-control unit 400 to the error check register (WRITE). The main control unit 100 reads the data written in the error check register in the sub control unit 400 (READ). Thus, the main control unit 100 verifies (inspects) the data by comparing the written data with the read data. This arbitrary data is stored, for example, in the ROM 185 shown in FIG. The main control unit 100 compares the written data with the read data, and if the written data and the read data are different, the main control unit 100 indicates that the sub-control unit 400 has malfunctioned. Judge that.
 ステップST4において、主制御部100は、副制御部400が動作異常をしていると判断すると、主制御部100は、ステップST5に移って次の動作を行う。
 ステップST5では、主制御部100は、副制御部400を強制的にリセット状態にする。このように、主制御部100は、副制御部400を強制的にリセット状態にすることで、副制御部400の指令動作を強制的に停止させることで、輸液ポンプ1の送液動作において、副制御部400に不具合があった場合に安全性を優先させる。
 しかも、主制御部100は、図4の表示部ドライバ130に指令を出して、表示部ドライバ130は、表示部3において「副制御部400(FPGA)エラー」を表示させる。この場合には、例えば、医療従事者に対する視認性を上げるために、表示部3の液晶表示装置の表示色は、バックライト点灯することで、例えば黄色画面から「白色画面」に変更され、「FPGA Error」と表示させる。これにより、医療従事者は、通常の表示部3の表示色とは異なる「白色画面」でエラー表示を見ることになるので、副制御部400の動作異常を容易にしかも確実に視認することができる。
In step ST4, when the main control unit 100 determines that the sub control unit 400 is operating abnormally, the main control unit 100 moves to step ST5 and performs the next operation.
In step ST5, the main control unit 100 forces the sub control unit 400 to be in a reset state. Thus, in the liquid feeding operation of the infusion pump 1, the main control unit 100 forcibly stops the command operation of the sub control unit 400 by forcing the sub control unit 400 into the reset state. When the sub-control unit 400 has a problem, priority is given to safety.
In addition, the main control unit 100 issues a command to the display unit driver 130 of FIG. 4, and the display unit driver 130 causes the display unit 3 to display “sub control unit 400 (FPGA) error”. In this case, for example, the display color of the liquid crystal display device of the display unit 3 is changed from a yellow screen to a “white screen”, for example, by turning on the backlight in order to increase the visibility for the medical staff. “FPGA Error” is displayed. Thereby, since the medical staff sees the error display on the “white screen” different from the display color of the normal display unit 3, the abnormal operation of the sub-control unit 400 can be easily and reliably visually recognized. it can.
 また、ステップST5では、主制御部100は、エラー表示ランプ3Wの赤LEDを、「赤点灯」させ、ブザー132を鳴動させ、駆動モータ61の動作を停止させる。また、必要に応じて、副制御部400は、スピーカ131を通じて、音声で「副制御部400(FPGA)エラー」を医療従事者に対して出すことで、ナースコール信号を発報する。
 このステップST5では、好ましくは、主制御部100は、ナースセンタ側の情報端末600に対しても「副制御部400(FPGA)エラー」を医療従事者に通知する。これにより、表示部3の液晶表示装置の表示色は、バックライト点灯することで、例えば黄色画面から「白色画面」に変更されて、「FPGA Error」と表示させる。しかも、ステップST3では、主制御部100は、エラー表示ランプ3WTの赤LEDを「赤点灯」させ、ブザー132Tを鳴動させ、スピーカ131Tを通じて音声で「副制御部400(FPGA)エラー」を医療従事者に対して出すことで、ナースコール信号を発報する。
In step ST5, the main control unit 100 turns on the red LED of the error display lamp 3W to “red light”, sounds the buzzer 132, and stops the operation of the drive motor 61. Further, as necessary, the sub-control unit 400 issues a nurse call signal by issuing a “sub-control unit 400 (FPGA) error” to the medical staff through the speaker 131 by voice.
In this step ST5, preferably, the main control unit 100 notifies the medical staff of the “sub control unit 400 (FPGA) error” also to the information terminal 600 on the nurse center side. As a result, the display color of the liquid crystal display device of the display unit 3 is changed from, for example, a yellow screen to a “white screen” by turning on the backlight to display “FPGA Error”. Moreover, in step ST3, the main control unit 100 “red-lights” the red LED of the error display lamp 3WT, sounds the buzzer 132T, and performs a medical “sub-control unit 400 (FPGA) error” by voice through the speaker 131T. A nurse call signal is issued by issuing to a person.
 これに対して、ステップST4において、主制御部100は、副制御部400が動作異常をしていないと判断すると、ステップST6に移り、輸液ポンプ1が所定の薬剤量を患者に送液したら、これまで行った正常な送液動作を停止する。
 以下、送液動作を停止する場合の好ましい制御について詳述する。正常な送液動作を停止させる場合も異常時に送液動作を停止させる場合も、主制御部100または副制御部400による送液駆動部60の駆動モータ61を停止させるための制御は同様である。
 図6を参照して、送液駆動部60のフィンガ構造体63が、輸液チューブ200を押圧することで、輸液チューブ200内の薬剤171を送液するフローをまず説明する。
 図6(A)から図6(F)は、輸液チューブ200をT方向にしごくことで、輸液チューブ200内を押圧して薬剤171を送液する、いわゆるミッドプレス方式の送液駆動部60を示している。ただし、この送液駆動部60は、輸液チューブ200を完全には押し潰さずに押圧することで、輸液チューブ200内の薬剤171を送液する。このように、ミッドプレス方式の送液駆動部60のフィンガ構造体63のうち、この例では、フィンガ63C、63D、63Eが輸液チューブ200を完全には押し潰さないので、輸液チューブ200における変形やヘタリが少ない範囲で、輸液チューブ200を一定量押し潰して、必要とする薬剤171の送液量を正確に送液できる。
 図6(A)では、輸液チューブ200は、上死点の位置にきているフィンガ63Bにより完全に圧閉されており、輸液チューブ200内にはT方向に薬剤171が流入する。
 図6(B)では、薬剤171の流入停止をして、輸液チューブ200は、上死点の位置にきているフィンガ63Fにより完全に圧閉されることで、薬剤171の一定量が、輸液チューブ200内において、フィンガ63Bとフィンガ63Fの間に確保できる。
 図6(C)では、下死点の位置にきているフィンガ63Bが輸液チューブ200を押すのを解除し、上死点の位置にきているフィンガ63Eが輸液チューブ200を押し、さらに図6(D)では、上死点の位置にきているフィンガ63D、63Cが輸液チューブ200を押すことで、薬剤171をT方向に吐出する。この場合に、上死点の位置にきているフィンガ63E、フィンガ63D、63Cは、輸液チューブ200を完全には押し潰さない。
 図6(E)では、上死点の位置にきているフィンガ63Bが再び輸液チューブ200を完全に圧閉し、薬剤171のT方向への吐出を停止する。そして、図6(F)では、下死点の位置にきているフィンガ63Bが輸液チューブ200を押すのを解除することで、図6(A)の初期の状態に戻る。以上説明した輸液チューブ200の押圧手順を繰り返すことで、薬剤171をT方向に送液するように制御される。
 ここで、正常な送液動作を停止させる場合も異常時に送液動作を停止させる場合も主制御部100または副制御部400により、フィンガ63Bが上死点の位置にきて輸液チューブ200を完全に圧閉される状態で送液動作を停止させる。
 なお、輸液チューブ200内を順次完全に押圧して薬剤171を送液する方式の輸液ポンプの場合には、最下流側のフィンガが上死点の位置にきている状態(所定位置)で送液動作を停止させる。
 なお、シリンジポンプ(不図示)での駆動モータの停止方法は、制御部の指令により、ステッピングモータのモータドライバから正転用の2相励磁のパルス状の入力電流波形を付与するのを停止させ、駆動モータのマグネットロータの正転を停止するように制御する。
 以上説明したように、主制御部100と副制御部400は、相互監視して、主制御部100は、副制御部400の異常動作(例えば暴走動作)を監視することができ、副制御部400は、主制御部100の異常動作(例えば暴走動作)を監視することができる。
On the other hand, in step ST4, when the main control unit 100 determines that the sub control unit 400 is not operating abnormally, the main control unit 100 moves to step ST6, and when the infusion pump 1 delivers a predetermined amount of drug to the patient, The normal liquid feeding operation performed so far is stopped.
Hereinafter, preferable control when stopping the liquid feeding operation will be described in detail. The control for stopping the drive motor 61 of the liquid supply drive unit 60 by the main control unit 100 or the sub-control unit 400 is the same whether the normal liquid supply operation is stopped or the liquid supply operation is stopped in the event of an abnormality. .
With reference to FIG. 6, the flow of feeding the medicine 171 in the infusion tube 200 by the finger structure 63 of the liquid feeding drive unit 60 pressing the infusion tube 200 will be described first.
6 (A) to 6 (F) show a so-called mid-press type liquid feeding drive unit 60 that pushes the inside of the infusion tube 200 and feeds the medicine 171 by squeezing the infusion tube 200 in the T direction. Show. However, the liquid feeding drive unit 60 feeds the medicine 171 in the infusion tube 200 by pressing the infusion tube 200 without completely crushing it. Thus, in this example, the fingers 63C, 63D, and 63E do not completely crush the infusion tube 200 among the finger structures 63 of the mid-press type liquid feeding drive unit 60. The infusion tube 200 can be crushed by a certain amount within the range where there is little settling, and the required amount of the drug 171 can be accurately fed.
In FIG. 6A, the infusion tube 200 is completely closed by the finger 63B located at the top dead center, and the drug 171 flows in the infusion tube 200 in the T direction.
In FIG. 6B, the inflow of the medicine 171 is stopped, and the infusion tube 200 is completely closed by the finger 63F located at the top dead center, so that a certain amount of the medicine 171 is infused. In the tube 200, it can be ensured between the fingers 63B and 63F.
In FIG. 6C, the finger 63B at the bottom dead center is released from pushing the infusion tube 200, the finger 63E at the top dead center pushes the infusion tube 200, and FIG. In (D), the fingers 63D and 63C at the top dead center position push the infusion tube 200 to discharge the medicine 171 in the T direction. In this case, the finger 63E and the fingers 63D and 63C that are at the top dead center do not completely crush the infusion tube 200.
In FIG. 6E, the finger 63B at the top dead center again completely closes the infusion tube 200 again, and stops the discharge of the medicine 171 in the T direction. In FIG. 6 (F), the finger 63B at the bottom dead center is released from pushing the infusion tube 200, thereby returning to the initial state of FIG. 6 (A). By repeating the pressing procedure of the infusion tube 200 described above, the medicine 171 is controlled to be fed in the T direction.
Here, both when the normal liquid feeding operation is stopped and when the liquid feeding operation is stopped in an abnormal state, the main control unit 100 or the sub-control unit 400 causes the finger 63B to reach the top dead center position, and the infusion tube 200 is completely removed. The liquid feeding operation is stopped in a state where the pressure is closed.
In the case of an infusion pump of the type in which the inside of the infusion tube 200 is completely pressed sequentially to deliver the medicine 171, the delivery is performed with the most downstream finger at the top dead center position (predetermined position). Stop fluid operation.
The method for stopping the drive motor with a syringe pump (not shown) is to stop applying a pulse-shaped input current waveform for two-phase excitation for forward rotation from the motor driver of the stepping motor according to the command of the control unit, Control to stop the forward rotation of the magnet rotor of the drive motor.
As described above, the main control unit 100 and the sub control unit 400 can monitor each other, and the main control unit 100 can monitor abnormal operation (for example, runaway operation) of the sub control unit 400. 400 can monitor abnormal operation (for example, runaway operation) of the main control unit 100.
 図4に示す主制御部100と副制御部400の相互監視の他に、主制御部100と副制御部400は、例えば次のような周辺要素の監視を行う。主制御部100は、図4に示す駆動モータ61の回転異常を、駆動モータ61の回転検出信号を、副制御部400を経由して監視する。
 主制御部100は、温度センサ180の温度センサ値(A/D値)TSを、副制御部400を介さないで直接監視することで、バッテリ113の動作状態の監視を行って、動作異常な時には例えば表示部3に表示し、ブザー132で警報する。主制御部100は、監視信号(バッテリ電圧検出値(A/D値))QSを、副制御部400を介さないで直接得ることで、バッテリ113の充電電圧異常を監視して、充電電圧異常である時には、例えば表示部3に表示し、ブザー132で警報する。
In addition to the mutual monitoring of the main control unit 100 and the sub control unit 400 shown in FIG. 4, the main control unit 100 and the sub control unit 400 monitor the following peripheral elements, for example. The main control unit 100 monitors the rotation detection signal of the drive motor 61 via the sub control unit 400 for the rotation abnormality of the drive motor 61 shown in FIG.
The main control unit 100 monitors the operating state of the battery 113 by directly monitoring the temperature sensor value (A / D value) TS of the temperature sensor 180 without passing through the sub-control unit 400, thereby causing abnormal operation. Sometimes, for example, it is displayed on the display unit 3 and an alarm is given by the buzzer 132. The main control unit 100 directly obtains the monitoring signal (battery voltage detection value (A / D value)) QS without passing through the sub-control unit 400, thereby monitoring the charging voltage abnormality of the battery 113 and charging voltage abnormality. Is displayed on the display unit 3, for example, and an alarm is given by the buzzer 132.
 その他に、主制御部100は、副制御部400を経由して、気泡センサ51の信号S1により、輸液チューブ内の気泡の有無を監視して、例えば表示部3に表示し、ブザー132で警報することもできる。主制御部100は、必要に応じて上流閉塞センサ52と下流閉塞センサ53にも接続されている。これにより、主制御部100は、上流閉塞センサ52からの信号S2と下流閉塞センサ53からの信号S3を直接得ることで、輸液チューブ200内の閉塞状態の監視をも行うことができる。主制御部100は、操作パネル4のボタン(キー)が連続でオンされた時のキー入力信号を、副制御部400を経由して監視することもできる。 In addition, the main control unit 100 monitors the presence / absence of bubbles in the infusion tube by the signal S1 of the bubble sensor 51 via the sub-control unit 400, displays the bubble on the display unit 3, and alerts the buzzer 132, for example. You can also The main control unit 100 is also connected to an upstream blockage sensor 52 and a downstream blockage sensor 53 as necessary. As a result, the main control unit 100 can directly monitor the closed state in the infusion tube 200 by directly obtaining the signal S2 from the upstream blockage sensor 52 and the signal S3 from the downstream blockage sensor 53. The main control unit 100 can also monitor the key input signal when the button (key) of the operation panel 4 is continuously turned on via the sub control unit 400.
 上述した本発明の実施形態の輸液ポンプ1では、図4に例示するように、主制御部100と副制御部400を備えており、副制御部400としてはFPGAを用いている。主制御部100に対して周辺要素として直接接続されているのは、例えばバッテリ監視部181と、電源コンバータ部112と、バッテリ113である。このように、バッテリ監視部181と電源コンバータ部112とバッテリ113が主制御部100に対して、副制御部400を経由しないで直接接続されているのは、バッテリ113の状態の監視と、電源コンバータ部112あるいはバッテリ113から主制御部100に対して電源供給を行うことが最も重要であり、バッテリ113の温度異常やバッテリ113の充電電圧異常が生じる事態、あるいは電源が供給されない事態があると、輸液ポンプ1が薬剤の送液動作に直接支障が生じて送液が行えなくなることを、最も重要な使用上の安全に関する監視事項としているからである。 The infusion pump 1 according to the embodiment of the present invention described above includes a main control unit 100 and a sub control unit 400 as illustrated in FIG. 4, and an FPGA is used as the sub control unit 400. The battery monitoring unit 181, the power converter unit 112, and the battery 113 are directly connected to the main control unit 100 as peripheral elements, for example. As described above, the battery monitoring unit 181, the power supply converter unit 112, and the battery 113 are directly connected to the main control unit 100 without passing through the sub-control unit 400. It is most important to supply power from the converter unit 112 or the battery 113 to the main control unit 100. When there is a situation where a temperature abnormality of the battery 113 or a charging voltage abnormality of the battery 113 occurs or a situation where power is not supplied This is because the fact that the infusion pump 1 directly impedes the liquid feeding operation of the medicine and cannot perform the liquid feeding is the most important monitoring item regarding safety in use.
 また、主制御部100と副制御部400を用意することで、主制御部100と副制御部400は相互監視を行い、周辺要素を監視しており、使い分けをしている。主制御部100は、上述したように、最も重量な使用上の安全に関する監視事項として例えばバッテリ113の温度異常やバッテリ113の充電電圧異常が生じる事態、あるいは電源が供給されない事態を監視しているので、送液を受ける患者の安全性を担保することができる。副制御部400は、その他の機能を監視している。
 これにより、主制御部100に上述した機能をすべて盛り込むのではなく、主制御部100と副制御部400に分けて機能を分担している。このため、主制御部100としては高性能で高価なCPU(中央処理部)のチップを採用する必要が無く、性能を落とした安価なCPUチップを採用することができるので、副制御部400を用いたとしても、主制御部100のコストダウンを図ることができる。
Also, by preparing the main control unit 100 and the sub control unit 400, the main control unit 100 and the sub control unit 400 perform mutual monitoring, monitor peripheral elements, and use them properly. As described above, the main control unit 100 monitors, for example, a situation in which a temperature abnormality of the battery 113 or a charging voltage abnormality of the battery 113 occurs, or a situation in which power is not supplied, as the most important monitoring items regarding safety in use. Therefore, the safety of the patient who receives the liquid can be ensured. The sub-control unit 400 monitors other functions.
As a result, the main control unit 100 does not incorporate all the functions described above, but the main control unit 100 and the sub control unit 400 share the functions. For this reason, it is not necessary to use a high-performance and expensive CPU (central processing unit) chip as the main control unit 100, and an inexpensive CPU chip with reduced performance can be used. Even if it is used, the cost of the main control unit 100 can be reduced.
 本発明の実施形態の医療用ポンプは、薬剤を患者に送液するための医療用ポンプであって、主制御部と、主制御部と、薬剤を送液するためのモータと、各種の情報を表示するための表示部に電気的に接続されている副制御部と、主制御部に直接接続され、主制御部と副制御部は、相互に動作異常を監視する構成としている。
 これにより、主制御部と副制御部は、相互に動作異常を監視する構成であるので、主制御部は、主制御部と副制御部のそれぞれの役割を分けることができる。このため、医療用ポンプが患者に対して薬剤を送液する際の安全性を確保でき、しかも主制御部としては性能を落とした安価な中央処理部を使用できるので、コストダウンが図れる。主制御部は、医療用ポンプにとって最も重要なバッテリから電源供給と温度センサからのバッテリの温度を直接監視できるので医療用ポンプが患者に対して薬剤を送液する際の安全性を確保でき、しかも主制御部としては性能を落とした安価なものを使用できるので、コストダウンが図れる。
A medical pump according to an embodiment of the present invention is a medical pump for feeding a drug to a patient, and includes a main control unit, a main control unit, a motor for feeding the drug, and various types of information. Are connected directly to the main control unit, and the main control unit and the sub control unit are configured to mutually monitor an abnormal operation.
Thereby, since the main control unit and the sub control unit are configured to mutually monitor the operation abnormality, the main control unit can separate the roles of the main control unit and the sub control unit. For this reason, it is possible to ensure the safety when the medical pump delivers the medicine to the patient, and furthermore, it is possible to use an inexpensive central processing unit with reduced performance as the main control unit, thereby reducing the cost. The main control unit can directly monitor the power supply from the battery, which is the most important for the medical pump, and the temperature of the battery from the temperature sensor, so that the medical pump can ensure the safety when sending the medicine to the patient, In addition, since an inexpensive one with reduced performance can be used as the main control unit, the cost can be reduced.
 副制御部が主制御部の動作異常を検出すると、副制御部はモータの動作を停止させ、主制御部が副制御部の動作異常を検出すると、主制御部はモータの動作を停止させる。これにより、主制御部と副制御部のいずれが異常動作しても、モータの動作を停止できるので、薬剤の送液動作を中止することができ、薬剤を送液する際に、主制御部と副制御部のいずれに不具合があっても、安全性を確保できる。 When the sub control unit detects an operation abnormality of the main control unit, the sub control unit stops the operation of the motor, and when the main control unit detects an operation abnormality of the sub control unit, the main control unit stops the operation of the motor. Thereby, even if any of the main control unit and the sub-control unit operates abnormally, the operation of the motor can be stopped, so that the liquid feeding operation of the medicine can be stopped, and when the medicine is fed, the main control section Safety can be ensured regardless of whether there is a problem with either of the sub-control unit.
 副制御部が、主制御部の動作異常を検出すると、表示部では白色画面が表示されて主制御部の動作異常を表示し、主制御部が、副制御部の動作異常を検出すると、表示部では白色画面が表示されて副制御部の動作異常を表示する。これにより、主制御部と副制御部のいずれが異常動作しても、表示部は白色画面を表示しながら主制御部の動作異常あるいは副制御部の動作異常を表示できるので、医療従事者は主制御部と副制御部のいずれが異常動作をしても視覚で確認することができる。 When the sub control unit detects an abnormal operation of the main control unit, a white screen is displayed on the display unit to display an operation error of the main control unit, and when the main control unit detects an operation abnormality of the sub control unit, the display The unit displays a white screen and displays an abnormal operation of the sub-control unit. As a result, even if either the main control unit or the sub control unit operates abnormally, the display unit can display an operation error of the main control unit or an operation error of the sub control unit while displaying a white screen. Even if either the main control unit or the sub control unit operates abnormally, it can be visually confirmed.
 警報を報知するためのブザーを有し、ブザーは、副制御部が主制御部の動作異常を検出すると警報を報知し、主制御部が副制御部の動作異常を検出すると警報を報知する。これにより、主制御部と副制御部のいずれが異常動作しても、ブザーにより警報を報知できるので、医療従事者は主制御部と副制御部のいずれが異常動作をしても聴覚で確認することができる。
 バッテリの充電電圧異常を監視するバッテリ監視部を有し、温度センサは、バッテリ監視部に配置されている。これにより、温度センサは、前記バッテリ監視部に配置されているものを用いるので、温度センサを別部品として搭載する必要が無いので、部品点数の低減が図れる。
The buzzer has a buzzer for notifying the alarm, and the buzzer notifies the alarm when the sub control unit detects an operation abnormality of the main control unit, and notifies the alarm when the main control unit detects the operation abnormality of the sub control unit. As a result, even if either the main control unit or the sub control unit operates abnormally, the buzzer can notify the alarm, so the medical staff can confirm by hearing whether the main control unit or the sub control unit operates abnormally. can do.
A battery monitoring unit that monitors battery charging voltage abnormality is provided, and the temperature sensor is disposed in the battery monitoring unit. Thereby, since the temperature sensor used in the battery monitoring unit is used, there is no need to mount the temperature sensor as a separate part, so the number of parts can be reduced.
 医療用ポンプの本体の上部分には、情報を表示する表示部と、操作ボタンを有する操作パネル部が配置され、医療用ポンプの本体の下部分は、薬剤を送液するための送液部材を配置する領域である。これにより、医療従事者は、本体の上部分の表示部の情報を確認しながら、医療用ポンプによる薬剤の送液作業を行うことができる。そして、医療従事者は、本体の上部分の表示部の情報を確認しながら、操作パネル部の操作ボタンを操作することができる。 A display unit for displaying information and an operation panel unit having operation buttons are arranged on the upper part of the main body of the medical pump, and a lower part of the main body of the medical pump is a liquid feeding member for feeding a medicine Is an area to be placed. Thereby, the medical worker can perform the liquid feeding operation of the medicine by the medical pump while confirming the information on the display unit on the upper part of the main body. Then, the medical worker can operate the operation buttons on the operation panel unit while confirming the information on the display unit on the upper part of the main body.
 本発明は、上記実施形態に限定されず、特許請求の範囲を逸脱しない範囲で種々の変更を行うことができる。
 本発明の医療用ポンプの実施形態は、輸液ポンプ1であるが、これに限らず本発明の医療用ポンプの別の実施形態としてはシリンジポンプであっても良い。
 このシリンジポンプは、例えば集中治療室(ICU)等で使用されて、患者に対して抗がん剤、麻酔剤、化学療法剤、輸血等、栄養剤等の薬剤の送液処置を、高い精度で比較的長時間行うことに用いられる。シリンジポンプの薬剤の流量制御は、他の輸液ポンプに比較して精密で優れている。薬剤を充填したシリンジ本体は、シリンジポンプの筐体に対してクランプを用いて動かないように装着され、シリンジポンプはシリンジ押子を押圧してシリンジ本体内の薬剤を正確に患者側に送液する。
The present invention is not limited to the above embodiment, and various modifications can be made without departing from the scope of the claims.
Although the embodiment of the medical pump of the present invention is the infusion pump 1, the present invention is not limited to this, and another embodiment of the medical pump of the present invention may be a syringe pump.
This syringe pump is used in, for example, an intensive care unit (ICU), etc., and performs high-accuracy treatment of a liquid such as an anticancer agent, anesthetic agent, chemotherapeutic agent, blood transfusion, etc. for a patient. Used for a relatively long time. The flow rate control of the drug in the syringe pump is precise and superior compared to other infusion pumps. The syringe body filled with the medicine is mounted so that it does not move using the clamp against the syringe pump housing, and the syringe pump presses the syringe pusher to accurately deliver the medicine in the syringe body to the patient side. To do.
 シリンジポンプを使用する治療室や手術室では、異なる収容量を有する複数種類のシリンジが予め用意されている。医療従事者は、複数種類のシリンジから必要とする収容量のシリンジを選択し、選択された収容量のシリンジを上述したシリンジポンプに対して装着する。シリンジがシリンジポンプに装着されると、シリンジ本体の外周面がシリンジポンプの凹部の内面に密着され、シリンジの本体フランジがシリンジポンプのはめ込み部分に対してはめ込まれることで、本体フランジが把持できる。そして、シリンジポンプのモータを駆動して、シリンジポンプの押圧部材が、シリンジ押子の押子フランジをシリンジ本体側に向けて少しずつ押すことで、シリンジ本体内の薬剤を、チューブを通じて患者に送液するようになっている。シリンジポンプの本体の上部分には、情報を表示する表示部と、操作ボタンを有する操作パネル部が配置され、シリンジポンプの本体の下部分は、薬剤を送液するための送液部材であるシリンジとこのシリンジに接続されたチューブを配置する領域である。これにより、医療従事者は、本体の上部分の表示部の情報を確認しながら、シリンジポンプによる薬剤の送液作業を行うことができる。そして、医療従事者は、本体の上部分の表示部の情報を確認しながら、操作パネル部の操作ボタンを操作することができる。
 上記実施形態の各構成は、その一部を省略したり、上記とは異なるように任意に組み合わせることができる。
In a treatment room or an operating room using a syringe pump, a plurality of types of syringes having different accommodation amounts are prepared in advance. A medical worker selects a required amount of syringe from a plurality of types of syringes, and attaches the selected amount of syringe to the above-described syringe pump. When the syringe is attached to the syringe pump, the outer peripheral surface of the syringe main body is brought into close contact with the inner surface of the concave portion of the syringe pump, and the main body flange can be gripped by the inset portion of the syringe pump. Then, the syringe pump motor is driven, and the pressing member of the syringe pump gradually pushes the pusher flange of the syringe pusher toward the syringe body, so that the medicine in the syringe body is sent to the patient through the tube. It comes to liquefy. On the upper part of the main body of the syringe pump, a display unit for displaying information and an operation panel unit having operation buttons are arranged, and the lower part of the main body of the syringe pump is a liquid feeding member for feeding a medicine. This is an area where a syringe and a tube connected to the syringe are arranged. Thereby, the medical worker can perform the liquid feeding operation of the medicine by the syringe pump while confirming the information on the display part of the upper part of the main body. Then, the medical worker can operate the operation buttons on the operation panel unit while confirming the information on the display unit on the upper part of the main body.
A part of each configuration of the above embodiment can be omitted, or can be arbitrarily combined so as to be different from the above.
 1・・・輸液ポンプ、3・・・表示部、50・・・チューブ装着部、60・・・送液駆動部、61・・・駆動モータ(モータの例)、100・・・主制御部、113・・・バッテリ、132・・・ブザー、180・・・温度センサ、181・・・バッテリ監視部、200・・・輸液チューブ、400・・・副制御部 DESCRIPTION OF SYMBOLS 1 ... Infusion pump, 3 ... Display part, 50 ... Tube mounting part, 60 ... Liquid feeding drive part, 61 ... Drive motor (example of motor), 100 ... Main control part , 113 ... battery, 132 ... buzzer, 180 ... temperature sensor, 181 ... battery monitoring unit, 200 ... infusion tube, 400 ... sub-control unit

Claims (6)

  1.  複数のフィンガにより輸液チューブを押圧することで薬剤を患者に送液するための医療用ポンプであって、
     主制御部と、
     前記主制御部と異なる回路素子により形成されており、前記薬剤を送液するためのモータと、各種の情報を表示するための表示部に電気的に接続され前記主制御部が直接制御しない被制御部を制御するための副制御部と、
     前記主制御部と前記副制御部は、相互に動作異常を監視する構成としたことを特徴とする医療用ポンプ。
    A medical pump for delivering a drug to a patient by pressing an infusion tube with a plurality of fingers,
    A main control unit;
    The circuit is formed by a circuit element different from that of the main control unit, and is electrically connected to a motor for feeding the medicine and a display unit for displaying various information, and the main control unit is not directly controlled. A sub-control unit for controlling the control unit;
    The medical pump according to claim 1, wherein the main control unit and the sub control unit are configured to mutually monitor an operation abnormality.
  2.  前記副制御部が前記主制御部の動作異常を検出すると、前記副制御部は前記フィンガが所定位置になるように前記モータの動作を制御して停止させ、前記主制御部が前記副制御部の動作異常を検出すると、前記主制御部は前記フィンガが所定位置になるように前記モータの動作を制御して停止させることを特徴とする請求項1に記載の医療用ポンプ。 When the sub control unit detects an operation abnormality of the main control unit, the sub control unit controls and stops the operation of the motor so that the finger is in a predetermined position, and the main control unit is configured to stop the sub control unit. 2. The medical pump according to claim 1, wherein when the operation abnormality is detected, the main control unit controls and stops the operation of the motor so that the finger is in a predetermined position.
  3.  前記副制御部が、前記主制御部の動作異常を検出すると、前記表示部では白色画面が表示されて前記主制御部の動作異常を表示し、前記主制御部が、前記副制御部の動作異常を検出すると、前記表示部では白色画面が表示されて前記副制御部の動作異常を表示することを特徴とする請求項2に記載の医療用ポンプ。 When the sub control unit detects an operation abnormality of the main control unit, a white screen is displayed on the display unit to display the operation abnormality of the main control unit, and the main control unit operates the sub control unit. 3. The medical pump according to claim 2, wherein when an abnormality is detected, a white screen is displayed on the display unit to display an operation abnormality of the sub-control unit.
  4.  前記副制御部が前記主制御部の動作異常を検出すると、前記副制御部は前記モータの動作を停止させ、前記主制御部が前記副制御部の動作異常を検出すると、前記主制御部は前記モータの動作を停止させる構成であり、
     前記副制御部が、前記主制御部の動作異常を検出すると、前記表示部では白色画面が表示されて前記主制御部の動作異常を表示し、前記主制御部が、前記副制御部の動作異常を検出すると、前記表示部では白色画面が表示されて前記副制御部の動作異常を表示する構成であり、
     かつ、警報を報知するためのブザーを有し、前記ブザーは、前記副制御部が前記主制御部の動作異常を検出すると前記警報を報知し、前記主制御部が前記副制御部の動作異常を検出すると前記警報を報知することを特徴とする請求項1に記載の医療用ポンプ。
    When the sub control unit detects an operation abnormality of the main control unit, the sub control unit stops the operation of the motor, and when the main control unit detects an operation abnormality of the sub control unit, the main control unit It is configured to stop the operation of the motor,
    When the sub control unit detects an operation abnormality of the main control unit, a white screen is displayed on the display unit to display the operation abnormality of the main control unit, and the main control unit operates the sub control unit. When an abnormality is detected, a white screen is displayed on the display unit and an operation abnormality of the sub-control unit is displayed.
    And a buzzer for notifying the alarm, wherein the buzzer notifies the alarm when the sub-control unit detects an abnormal operation of the main control unit, and the main control unit abnormally operates the sub-control unit. The medical pump according to claim 1, wherein the alarm is notified when an error is detected.
  5.  前記バッテリの充電電圧異常を監視するバッテリ監視部を有し、前記温度センサは、前記バッテリ監視部に配置されていることを特徴とする請求項4に記載の医療用ポンプ。 The medical pump according to claim 4, further comprising a battery monitoring unit that monitors a charging voltage abnormality of the battery, wherein the temperature sensor is disposed in the battery monitoring unit.
  6.  前記医療用ポンプの本体の上部分には、前記表示部と、操作ボタンを有する操作パネル部が配置され、前記医療用ポンプの本体の下部分は、前記薬剤を送液するための送液部材を配置する領域であることを特徴とする請求項1ないし5のいずれかに記載の医療用ポンプ。 An operation panel unit having the display unit and operation buttons is disposed on an upper part of the main body of the medical pump, and a lower part of the main body of the medical pump is a liquid feeding member for feeding the medicine. The medical pump according to any one of claims 1 to 5, wherein the medical pump is a region in which the pump is disposed.
PCT/JP2012/006036 2012-09-21 2012-09-21 Medical pump WO2014045323A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/JP2012/006036 WO2014045323A1 (en) 2012-09-21 2012-09-21 Medical pump

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2012/006036 WO2014045323A1 (en) 2012-09-21 2012-09-21 Medical pump

Publications (1)

Publication Number Publication Date
WO2014045323A1 true WO2014045323A1 (en) 2014-03-27

Family

ID=50340685

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2012/006036 WO2014045323A1 (en) 2012-09-21 2012-09-21 Medical pump

Country Status (1)

Country Link
WO (1) WO2014045323A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005516644A (en) * 2001-10-09 2005-06-09 スコット・ラボラトリーズ・インコーポレイテッド Apparatus and method for alleviating pain or anxiety associated with medical or surgical procedures in conscious patients according to appropriate clinical discovery
JP2009502109A (en) * 2005-07-21 2009-01-22 ハンヒ シン Portable device charger using solar cells
JP2009521258A (en) * 2005-12-21 2009-06-04 オプテイスカン・バイオメデイカル・コーポレーシヨン Analyte detection system and method with periodic sample extraction and body fluid analyzer
WO2011125439A1 (en) * 2010-03-31 2011-10-13 テルモ株式会社 Integrated circuit and medical instrument using same
JP2012010940A (en) * 2010-06-30 2012-01-19 Terumo Corp Function-supplementing integrated circuit and integrated circuit system, and medical instrument using the same
JP2012010956A (en) * 2010-06-30 2012-01-19 Terumo Corp Infusion pump

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005516644A (en) * 2001-10-09 2005-06-09 スコット・ラボラトリーズ・インコーポレイテッド Apparatus and method for alleviating pain or anxiety associated with medical or surgical procedures in conscious patients according to appropriate clinical discovery
JP2009502109A (en) * 2005-07-21 2009-01-22 ハンヒ シン Portable device charger using solar cells
JP2009521258A (en) * 2005-12-21 2009-06-04 オプテイスカン・バイオメデイカル・コーポレーシヨン Analyte detection system and method with periodic sample extraction and body fluid analyzer
WO2011125439A1 (en) * 2010-03-31 2011-10-13 テルモ株式会社 Integrated circuit and medical instrument using same
JP2012010940A (en) * 2010-06-30 2012-01-19 Terumo Corp Function-supplementing integrated circuit and integrated circuit system, and medical instrument using the same
JP2012010956A (en) * 2010-06-30 2012-01-19 Terumo Corp Infusion pump

Similar Documents

Publication Publication Date Title
JP6207516B2 (en) Infusion pump
JP6023200B2 (en) Infusion pump
JP6433294B2 (en) Infusion pump
WO2012144219A1 (en) Infusion pump
JP6240620B2 (en) Infusion pump comprising an infusion probe and an infusion probe
JP6914848B2 (en) Medical pump and its control method
WO2014049656A1 (en) Infusion pump
JP5805415B2 (en) Infusion pump
JP5996843B2 (en) Infusion pump
JP6069333B2 (en) Medical pump
JP6285369B2 (en) Infusion pump
JP5897815B2 (en) Infusion pump
US20230310735A1 (en) Electronically controlled intravenous infusion pump
JP5740187B2 (en) Infusion pump
WO2014045323A1 (en) Medical pump
WO2014049657A1 (en) Medical-use pump
WO2014030184A1 (en) Infusion pump
JP6276823B2 (en) Infusion pump
WO2014045328A1 (en) Infusion pump
WO2013125576A1 (en) Medical pump
JP2012200422A (en) Infusion pump
JP2018157934A (en) Clamp form detection system and clamp form detector
WO2014020636A1 (en) Infusion pump

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12884894

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12884894

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP